Skip to content

GALAPAGOS

Active
Public limited companyfounded 199927 yrs activeSchaliënhoevedreef 20T, 2800 Mechelen, BelgiumKBO/BCE: BE 0466.460.429
Summary

GALAPAGOS has been active since 1999 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €2.83bn and a net result of €47.8m. Equity remains stable across the filed fiscal years (±1.7% per year). The computed 12-month bankruptcy probability is 0.2% (very low).

Checked score

Score 2024
Axes · tick = 2023
Profitability80▼-4
Solvency95▲+5
Growth69▼-16
Track record100
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €2m at 30 days acceptable
Liquidity ample (current ratio 26.11 against 19.61 in 2023; short-term debt: 3.4% and cash: 1.5% of total assets), and 30% of the assets are financed with debt.
Credit check for your own amount and term

Open the credit simulator : see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024
Solvency, return and age of the figures
Solvency
70%
Return on assets
1.2%
Age of the figures
21 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 27 years 0 30 y
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 72
Relative position
BE, all sectors
reference
Scientific research and development (NACE 72)
about 30% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-05-2026, 63 days ahead of the deadline.
NBB · 5 filings
Deviation from the deadline
2025
63 d early
2024
70 d early
2023
41 d early
2022
81 d early
2021
93 d early
← before the deadline after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
26-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

GALAPAGOS was incorporated on 6 July 1999.1 Between 2005 and 2022 the capital was increased 51 times.234 The board currently has 22 members; Dr. Raj Parekh has served longest, since 2005.5 Revenue grew from EUR 219 million in 2018 to EUR 303 million in 2024 and headcount from 236 to 292 full-time equivalents.6

  1. 1Crossroads Bank for Enterprises
  2. 2Belgian State Gazette, 22-06-2005
  3. 3Belgian State Gazette, 06-09-2019
  4. 4Belgian State Gazette, 24-03-2022
  5. 5Belgian State Gazette, 27-05-2022
  6. 6National Bank, annual accounts 2018 and 2024

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2024, full schema, statutory accounts

Turnover
€303.4m▼ 51.8%
2023 · €628.9m
EBIT margin
-68.5%▼ 79.4pp
2023 · 11.0%
Net result
€47.8m▼ 82.4%
2023 · €271.3m
Working capital
€3.48bn▼ 7.3%
2023 · €3.76bn
Trend over the years

Click a name to add, emphasise or remove a line.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20192020202120232024
Turnover€902.8m▲ 312%€558.8m▼ 38.1%€503.4m▼ 9.9%€628.9m-€303.4m▼ 51.8%
Operating result€393.9m-€108.9m-€191.7m▼ 75.9%€69.0m--€207.7m
Net result€379.0m-€196.0m-€92.7m▲ 52.7%€271.3m-€47.8m▼ 82.4%
EBIT margin43.6%▲ 108.2pp-19.5%▼ 63.1pp-38.1%▼ 18.6pp11.0%--68.5%▼ 79.4pp
Equity€2.90bn▲ 147%€2.73bn▼ 5.8%€2.64bn▼ 3.3%€2.78bn-€2.83bn▲ 1.7%
Total assets€6.00bn▲ 321%€5.60bn▼ 6.7%€5.12bn▼ 8.6%€4.30bn-€4.04bn▼ 6.0%
Debt€3.11bn▲ 1,126%€2.86bn▼ 8.0%€2.47bn▼ 13.5%€1.51bn-€1.20bn▼ 20.5%
Working capital€5.68bn▲ 367%€5.24bn▼ 7.8%€4.77bn▼ 8.9%€3.76bn-€3.48bn▼ 7.3%
Staff (FTE)308.4▲ 30.6%436.3▲ 41.5%486.5▲ 11.5%368.6-291.5▼ 20.9%
Result per fiscal year
Operating resultNet result
-€400.0m-€200.0m€0€200.0m€400.0mOperating result 2019: €393.9m€393.9mNet result 2019: €379.0m€379.0mOperating result 2020: -€108.9m-€108.9mNet result 2020: -€196.0m-€196.0mOperating result 2021: -€191.7m-€191.7mNet result 2021: -€92.7m-€92.7mOperating result 2023: €69.0m€69.0mNet result 2023: €271.3m€271.3mOperating result 2024: -€207.7m-€207.7mNet result 2024: €47.8m€47.8m20192020202120232024-€400m-€200m€0€200mOperating result 2021: -€191.7m-€192mNet result 2021: -€92.7m-€93mOperating result 2023: €69.0m€69mNet result 2023: €271.3m€271mOperating result 2024: -€207.7m-€208mNet result 2024: €47.8m€48m202120232024
The operating result turns negative in 2024: a loss of €207.7m after €69.0m in 2023, the lowest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €4.04bn
Fixed assets €423.1m ▲ 23.4%
Current assets €3.62bn ▼ 8.5%
Equity and liabilities €4.04bn
Equity €2.83bn ▲ 1.7%
Provisions €17.5m ▲ 25.5%
Debt €1.20bn ▼ 20.5%
Debt's share of the balance-sheet total falls from 35.0% to 29.6%. Equity is higher and debt is lower.
Key figures and ratios
2024 value · change against 2023
EBITDA
€75.7m▼
2023 · €429.5m
Cash flow
€331.3m▼
2023 · €631.8m
Current ratio
26.11▲
2023 · 19.61
Quick ratio
25.74▲
2023 · 19.24
Debt to equity
0.42▼
2023 · 0.54
ROE
1.7%▼
2023 · 9.8%
ROA
1.2%▼
2023 · 6.3%
Interest coverage
52.11▼
2023 · 105.97
Debt ≤ 1 year
€138.7m▼
2023 · €201.9m
Income taxes
-€17.1m▲
2023 · -€26.3m
Staff costs
€57.9m▼
2023 · €73.6m
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
Filed annual accounts As filed with the NBB · 2024 against 2023 · 94 lines
Balance sheet Code20232024
Assets
Total assets20/58€4.30bn€4.04bn▼
Fixed assets21/28€342.8m€423.1m▲
Intangible fixed assets21€58.3m€109.1m▲
Tangible fixed assets22/27€16.0m€16.5m▲
Land and buildings22€871,570€354,535▼
Plant, machinery and equipment23€11.7m€13.3m▲
Furniture and vehicles24€1.2m€992,909▼
Leasing and similar rights25€0-
Other tangible fixed assets26€0-
Assets under construction and advance payments27€2.3m€1.8m▼
Financial fixed assets28€268.4m€297.5m▲
Affiliated companies280/1€249.4m€245.2m▼
Participating interests280€204.1m€198.3m▼
Amounts receivable281€45.3m€46.8m▲
Companies linked by participating interests282/3€1€1=
Participating interests282€1€1=
Other financial fixed assets284/8€19.0m€52.3m▲
Shares284€14.0m€50.8m▲
Amounts receivable and cash guarantees285/8€5.0m€1.5m▼
Current assets29/58€3.96bn€3.62bn▼
Amounts receivable after more than one year29€122.1m€122.2m▲
Trade receivables290€0-
Other amounts receivable291€122.1m€122.2m▲
Stocks and contracts in progress3€74.0m€51.2m▼
Stocks30/36€74.0m€51.2m▼
Raw materials and consumables30/31€55.3m€51.2m▼
Work in progress32€12.6m€0▼
Goods purchased for resale34€6.1m€0▼
Amounts receivable within one year40/41€91.1m€108.3m▲
Trade receivables40€27.0m€32.7m▲
Other amounts receivable41€64.1m€75.6m▲
Current investments50/53€3.58bn€3.25bn▼
Other investments51/53€3.58bn€3.25bn▼
Cash at bank and in hand54/58€69.4m€60.1m▼
Deferred charges and accrued income490/1€25.5m€33.2m▲
Equity and liabilities
Total equity and liabilities10/49€4.30bn€4.04bn▼
Equity10/15€2.78bn€2.83bn▲
Contributions10/11€3.02bn€3.02bn=
Capital10€356.4m€356.4m=
Issued capital100€356.4m€356.4m=
Outside capital11€2.66bn€2.66bn=
Share premium1100/10€2.66bn€2.66bn=
Profit (loss) carried forward14-€235.9m-€188.1m▲
Provisions and deferred taxes16€14.0m€17.5m▲
Provisions for liabilities and charges160/5€14.0m€17.5m▲
Other liabilities and charges164/5€14.0m€17.5m▲
Amounts payable17/49€1.51bn€1.20bn▼
Amounts payable within one year42/48€201.9m€138.7m▼
Trade debts44€129.2m€92.5m▼
Suppliers440/4€129.2m€92.5m▼
Taxes, remuneration and social security45€23.8m€12.0m▼
Taxes450/3€2.3m€663,637▼
Remuneration and social security454/9€21.4m€11.3m▼
Other amounts payable47/48€48.9m€34.2m▼
Accrued charges and deferred income492/3€1.30bn€1.06bn▼
Income statement Code20232024
Operating income70/76A€1.00bn€596.1m▼
Turnover70€628.9m€303.4m▼
Change in stocks of work in progress, finished goods and contracts in progress71€6.8m-€12.6m▼
Own construction capitalised72€352.6m€265.4m▼
Other operating income74€16.1m€39.9m▲
Non-recurring operating income76A€547,659€0▼
Operating charges60/66A€936.0m€803.9m▼
Goods for resale, raw materials and consumables60€28.7m€46.4m▲
Purchases600/8€43.2m€35.3m▼
Change in stocks: decrease (increase)609-€14.5m€11.1m▲
Services and other goods61€397.1m€334.6m▼
Remuneration, social security and pensions62€73.6m€57.9m▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€360.5m€283.5m▼
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4-€10.6m
Provisions for liabilities and charges: additions (uses and reversals)635/8€4.2m€3.6m▼
Other operating charges640/8€70.8m€27.1m▼
Non-recurring operating charges66A€1.0m€40.2m▲
Operating profit (loss)9901€69.0m-€207.7m▼
Financial income75/76B€213.5m€257.1m▲
Recurring financial income75€213.5m€201.1m▼
Income from financial fixed assets750€109.5m€12.3m▼
Income from current assets751€102.0m€118.6m▲
Other financial income752/9€2.0m€70.1m▲
Non-recurring financial income76B-€56.0m
Financial charges65/66B€37.5m€18.6m▼
Recurring financial charges65€27.4m€18.6m▼
Debt charges650€4.1m€1.5m▼
Write-downs on current assets other than stocks, contracts in progress and trade receivables: additions (reversals)651-€9.1m-
Other financial charges652/9€32.5m€17.2m▼
Non-recurring financial charges66B€10.1m-
Profit (loss) for the period before taxes9903€245.0m€30.7m▼
Income taxes67/77-€26.3m-€17.1m▲
Taxes670/3€72,259€49,571▼
Tax adjustments and reversals of tax provisions77€26.4m€17.2m▼
Profit (loss) for the period9904€271.3m€47.8m▼
Profit (loss) for the period to be appropriated9905€271.3m€47.8m▼
Appropriation of the result
Profit (loss) to be appropriated9906-€235.9m-€188.1m▲
Profit (loss) brought forward from the previous period14P-€507.2m-€235.9m▲
Social balance
Average headcount (FTE)9087368.6291.5▼

The notes to these accounts (117 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20192020202120232024Change
Operating income70/76A--€916.0m€1.00bn€596.1m▼ 40.7%
Turnover70€902.8m€558.8m€503.4m€628.9m€303.4m▼ 51.8%
Change in stocks of work in progress, finished goods and contracts in progress71--€1.4m€6.8m-€12.6m▼ 285%
Own construction capitalised72--€392.7m€352.6m€265.4m▼ 24.7%
Other operating income74--€18.5m€16.1m€39.9m▲ 148%
Non-recurring operating income76A---€547,659€0▼ 100%
Operating charges60/66A--€1.11bn€936.0m€803.9m▼ 14.1%
Goods for resale, raw materials and consumables60--€13.1m€28.7m€46.4m▲ 61.6%
Purchases600/8--€31.7m€43.2m€35.3m▼ 18.3%
Change in stocks: decrease (increase)609---€18.6m-€14.5m€11.1m▲ 176%
Services and other goods61--€500.0m€397.1m€334.6m▼ 15.7%
Remuneration, social security and pensions62--€70.4m€73.6m€57.9m▼ 21.3%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€403.3m€467.8m€401.8m€360.5m€283.5m▼ 21.4%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4--€7,919-€10.6m-
Provisions for liabilities and charges: additions (uses and reversals)635/8---€2.3m€4.2m€3.6m▼ 15.5%
Other operating charges640/8--€120.7m€70.8m€27.1m▼ 61.7%
Non-recurring operating charges66A--€4.1m€1.0m€40.2m▲ 3,776%
Operating profit (loss)9901€393.9m-€108.9m-€191.7m€69.0m-€207.7m▼ 401%
Financial income75/76B--€119.2m€213.5m€257.1m▲ 20.4%
Recurring financial income75€27.5m€25.8m€85.8m€213.5m€201.1m▼ 5.8%
Income from financial fixed assets750--€583€109.5m€12.3m▼ 88.7%
Income from current assets751--€3.0m€102.0m€118.6m▲ 16.3%
Other financial income752/9--€82.7m€2.0m€70.1m▲ 3,391%
Non-recurring financial income76B--€33.5m-€56.0m-
Financial charges65/66B--€40.5m€37.5m€18.6m▼ 50.3%
Recurring financial charges65€64.0m€139.9m€28.1m€27.4m€18.6m▼ 32.0%
Debt charges650€1.2m€12.3m€14.5m€4.1m€1.5m▼ 64.1%
Write-downs on current assets other than stocks, contracts in progress and trade receivables: additions (reversals)651--€6.4m-€9.1m--
Other financial charges652/9--€7.2m€32.5m€17.2m▼ 47.0%
Non-recurring financial charges66B--€12.3m€10.1m--
Profit (loss) for the period before taxes9903€357.4m-€217.5m-€112.9m€245.0m€30.7m▼ 87.5%
Income taxes67/77-€21.6m-€21.6m-€20.2m-€26.3m-€17.1m▲ 34.9%
Taxes670/3--€700,112€72,259€49,571▼ 31.4%
Tax adjustments and reversals of tax provisions77--€20.9m€26.4m€17.2m▼ 34.9%
Profit (loss) for the period9904€379.0m-€196.0m-€92.7m€271.3m€47.8m▼ 82.4%
Profit (loss) for the period to be appropriated9905€379.0m-€196.0m-€92.7m€271.3m€47.8m▼ 82.4%
Line20192020202120232024Change
Assets
Total assets20/58€6.00bn€5.60bn€5.12bn€4.30bn€4.04bn▼ 6.0%
Fixed assets21/28€85.0m€130.5m€107.3m€342.8m€423.1m▲ 23.4%
Intangible fixed assets21€11.1m€54.8m€48.3m€58.3m€109.1m▲ 87.0%
Tangible fixed assets22/27€9.5m€14.5m€15.7m€16.0m€16.5m▲ 3.1%
Land and buildings22--€2.6m€871,570€354,535▼ 59.3%
Plant, machinery and equipment23--€9.5m€11.7m€13.3m▲ 14.2%
Furniture and vehicles24--€2.1m€1.2m€992,909▼ 19.4%
Leasing and similar rights25--€0€0--
Other tangible fixed assets26--€0€0--
Assets under construction and advance payments27--€1.5m€2.3m€1.8m▼ 18.3%
Financial fixed assets28€64.4m€61.2m€43.3m€268.4m€297.5m▲ 10.8%
Affiliated companies280/1--€41.9m€249.4m€245.2m▼ 1.7%
Participating interests280--€41.9m€204.1m€198.3m▼ 2.8%
Amounts receivable281---€45.3m€46.8m▲ 3.4%
Companies linked by participating interests282/3--€1€1€1=
Participating interests282--€1€1€1=
Other financial fixed assets284/8--€1.4m€19.0m€52.3m▲ 176%
Shares284---€14.0m€50.8m▲ 264%
Amounts receivable and cash guarantees285/8--€1.4m€5.0m€1.5m▼ 70.6%
Current assets29/58€5.92bn€5.47bn€5.01bn€3.96bn€3.62bn▼ 8.5%
Amounts receivable after more than one year29--€92.5m€122.1m€122.2m▲ 0.1%
Trade receivables290--€0€0--
Other amounts receivable291--€92.5m€122.1m€122.2m▲ 0.1%
Stocks and contracts in progress3€251,576€354,925€20.4m€74.0m€51.2m▼ 30.8%
Stocks30/36--€20.4m€74.0m€51.2m▼ 30.8%
Raw materials and consumables30/31--€14.4m€55.3m€51.2m▼ 7.4%
Work in progress32--€1.4m€12.6m€0▼ 100%
Goods purchased for resale34--€4.6m€6.1m€0▼ 100%
Amounts receivable within one year40/41€150.8m€207.4m€209.4m€91.1m€108.3m▲ 19.0%
Trade receivables40--€92.9m€27.0m€32.7m▲ 21.3%
Other amounts receivable41--€116.6m€64.1m€75.6m▲ 18.0%
Current investments50/53€4.87bn€3.92bn€3.48bn€3.58bn€3.25bn▼ 9.2%
Other investments51/53--€3.48bn€3.58bn€3.25bn▼ 9.2%
Cash at bank and in hand54/58€886.8m€1.20bn€1.20bn€69.4m€60.1m▼ 13.3%
Deferred charges and accrued income490/1--€9.5m€25.5m€33.2m▲ 30.2%
Equity and liabilities
Total equity and liabilities10/49€6.00bn€5.60bn€5.12bn€4.30bn€4.04bn▼ 6.0%
Equity10/15€2.90bn€2.73bn€2.64bn€2.78bn€2.83bn▲ 1.7%
Contributions10/11€349.8m€353.8m€3.01bn€3.02bn€3.02bn=
Capital10--€354.6m€356.4m€356.4m=
Issued capital100--€354.6m€356.4m€356.4m=
Outside capital11--€2.65bn€2.66bn€2.66bn=
Share premium1100/10--€2.65bn€2.66bn€2.66bn=
Profit (loss) carried forward14-€80.5m-€276.5m-€369.2m-€235.9m-€188.1m▲ 20.3%
Provisions and deferred taxes16-€11.2m€8.9m€14.0m€17.5m▲ 25.5%
Provisions for liabilities and charges160/5--€8.9m€14.0m€17.5m▲ 25.5%
Other liabilities and charges164/5--€8.9m€14.0m€17.5m▲ 25.5%
Amounts payable17/49€3.11bn€2.86bn€2.47bn€1.51bn€1.20bn▼ 20.5%
Amounts payable after more than one year17€3.4m-€1.5m---
Other amounts payable178/9--€1.5m---
Amounts payable within one year42/48€239.3m€230.6m€240.6m€201.9m€138.7m▼ 31.3%
Financial debts43--€652,249---
Other loans439--€652,249---
Trade debts44€211.1m€195.9m€149.4m€129.2m€92.5m▼ 28.5%
Suppliers440/4--€149.4m€129.2m€92.5m▼ 28.5%
Taxes, remuneration and social security45--€16.7m€23.8m€12.0m▼ 49.5%
Taxes450/3--€1.6m€2.3m€663,637▼ 71.3%
Remuneration and social security454/9--€15.1m€21.4m€11.3m▼ 47.2%
Other amounts payable47/48--€73.8m€48.9m€34.2m▼ 29.9%
Accrued charges and deferred income492/3--€2.23bn€1.30bn€1.06bn▼ 18.8%
Line20192020202120232024Change
Profit (loss) for the period9904€379.0m-€196.0m-€92.7m€271.3m€47.8m▼ 82.4%
+ Depreciation and write-downs630€403.3m€467.8m€401.8m€360.5m€283.5m▼ 21.4%
Operating cash flow (approximation)€782.3m€271.8m€309.1m€631.8m€331.3m▼ 47.6%
Investment in fixed assets (approximation)--€513.3m-€378.6m--€363.8m-
Change in cash-€314.0m€3.1m--€9.2m-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
23-09
State Gazette act Board meeting · Power of attorney
9 facts ▸
  • Board meeting, 05-08-2026
  • Power of attorney, Jeroen De Schauwer
  • Power of attorney, Reginald Neirynck
  • Power of attorney, Filip Lecoutre
  • Power of attorney, Luka Roosen
  • Power of attorney, Janne Dehouck
  • Power of attorney
  • Power of attorney, Carmen Theunis
  • Power of attorney
11-09
State Gazette act Miscellaneous
31-07
State Gazette act Resignation: Paulo Pacheco da Fontoura (niet uitvoerend onafhankelijk bestuurder)
2 facts ▸
  • Board meeting, 09/07/2026
  • Director resignation, Paulo Pacheco da Fontoura (niet uitvoerend onafhankelijk bestuurder)
02-07
State Gazette act Miscellaneous
05-06
NBB filing Annual accounts filed
fiscal year 2025 · full schema
29-05
NBB filing Annual accounts filed
fiscal year 2025 · consolidated
31-03
State Gazette act Miscellaneous
30-03
State Gazette act Appointment: Paulo Fontoura (niet uitvoerende onafhankelijke bestuurder)
Resignations: Dr. Susanne Schaffert (niet uitvoerende onafhankelijke bestuurder) and Annelies Missotten (lid van het directiecomité als chief human resources officer)4 facts ▸
  • Board meeting
  • Director appointment, Paulo Fontoura (niet uitvoerende onafhankelijke bestuurder)
  • Director resignation, Dr. Susanne Schaffert (niet uitvoerende onafhankelijke bestuurder)
  • Director resignation, Annelies Missotten (lid van het directiecomité als chief human resources officer)
12-03
State Gazette act Miscellaneous
06-02
State Gazette act Miscellaneous
2025
30-12
State Gazette act Resignations: Dr. Elisabeth Svanberg, Dr. Susanne Schaffert and 2 others
Appointments: Dr. Neil Johnston, Devang Bhuva and 5 others12 facts ▸
  • Board meeting, 16/10/2025
  • Director resignation, Dr. Elisabeth Svanberg (niet uitvoerende onafhankelijke bestuurder)
  • Director resignation, Dr. Susanne Schaffert (niet uitvoerende onafhankelijke bestuurder)
  • Director resignation, Andrew Dickinson (niet uitvoerende niet onafhankelijke bestuurder)
  • Director appointment, Dr. Neil Johnston (niet uitvoerende onafhankelijke bestuurder)
  • Director appointment, Devang Bhuva (niet uitvoerende niet onafhankelijke bestuurder)
  • Director appointment, Fred Blakeslee (general counsel en lid van het directiecomité)
  • Director resignation, Valeria Cnossen (general counsel en lid van het directiecomité)
  • Director appointment, Jérôme Contamine (chair of the board)
  • Director appointment, Henry Gosebruch (chief executive officer)
  • Director appointment, Aaron Cox (chief financial officer)
  • Director appointment, Annelies Missotten (chief human resources officer)
15-12
State Gazette act Miscellaneous
Show earlier events
10-10
State Gazette act Restructuring
Demerger3 facts ▸
  • Board meeting, 30/09/2025
  • Board meeting, 01/10/2025
  • Demerger
11-09
State Gazette act Resignations: Peter Guenter, Simon Sturge and Thad Huston
Appointments: Dawn Svoronos, Jane Griffiths and 5 others15 facts ▸
  • Board meeting, 24/06/2025
  • Director resignation, Peter Guenter (director)
  • Director resignation, Simon Sturge (director)
  • Director appointment, Dawn Svoronos (niet uitvoerende onafhankelijke bestuurder)
  • Director appointment, Jane Griffiths (niet uitvoerende onafhankelijke bestuurder)
  • Board meeting, 21/06/2025
  • Director appointment, Aaron Cox (chief financial officer)
  • Director appointment, Aaron Cox (member of the executive committee)
  • Director resignation, Thad Huston (chief operating officer)
  • Director resignation, Thad Huston (chief financial officer)
  • Director resignation, Thad Huston (member of the executive committee)
  • Director appointment, Jérôme Contamine (chair of the board)
  • +3 further facts in this act
28-08
State Gazette act Miscellaneous
14-08
State Gazette act Miscellaneous
19-06
State Gazette act Miscellaneous
11-06
State Gazette act Appointments: Oleg Nodelman, BDO Bedrijfsrevisoren BV and 5 others
Resignations: Daniel Baker (director) and Stoffels IMC BV (voorzitter en lid van de raad van bestuur en chief executive officer en lid van het directiecomité) · Permanent representative: Ellen Lombaerts · Mandate compensation14 facts ▸
  • General meeting, 29/04/2025
  • Director appointment, Oleg Nodelman (non-executive director)
  • Mandate compensation, Oleg Nodelman
  • Director resignation, Daniel Baker (director)
  • Auditor appointment, BDO Bedrijfsrevisoren BV (commissaris voor de waarborging van de duurzaamheidsverslaggeving)
  • Permanent representative, Ellen Lombaerts
  • Board meeting, 12/05/2025
  • Director resignation, Stoffels IMC BV (voorzitter en lid van de raad van bestuur en chief executive officer en lid van het directiecomité)
  • Director appointment, Henry Gosebruch (executive director)
  • Director appointment, Henry Gosebruch (chief executive officer en lid van het directiecomité)
  • Director appointment, Jérôme Contamine (chair of the board)
  • Director appointment, Thad Huston (chief operating officer en chief financial officer)
  • +2 further facts in this act
05-06
State Gazette act Miscellaneous
22-05
NBB filing Annual accounts filed
fiscal year 2024 · full schema
22-05
NBB filing Annual accounts filed
fiscal year 2024 · consolidated
02-01
State Gazette act Miscellaneous
2024
05-12
State Gazette act Resignation: Daniel G. Baker (independent director)
Appointments: Oleg Nodelman, Dr. Paul Stoffels and 10 others · Permanent representative: Dr. Paul Stoffels · Mandate compensation19 facts ▸
  • Board meeting, 06/10/2024
  • Director resignation, Daniel G. Baker (independent director)
  • Director appointment, Oleg Nodelman (niet uitvoerende en niet onafhankelijke bestuurder)
  • Mandate compensation, Oleg Nodelman
  • Permanent representative, Dr. Paul Stoffels (permanent vertegenwoordiger)
  • Director appointment, Dr. Paul Stoffels (chair of the board)
  • Director appointment, Dr. Linda Higgins (director)
  • Director appointment, Andrew Dickinson (director)
  • Director appointment, Jérôme Contamine (independent director)
  • Director appointment, Peter Guenter (independent director)
  • Director appointment, Simon Sturge (independent director)
  • Director appointment, Dr. Elisabeth Svanberg (independent director)
  • +7 further facts in this act
23-08
State Gazette act Miscellaneous
22-08
NBB filing Annual accounts filed
fiscal year 2023 · consolidated
10-07
State Gazette act Miscellaneous
04-07
State Gazette act Resignation: Daniel O'Day (director)
Appointments: Andrew Dickinson, Susanne Schaffert and 6 others · Reappointment: Elisabeth Svanberg (onafhankelijk niet uitvoerend lid van de raad van bestuur) · Permanent representatives: Ellen Lombaerts and Paul Stoffels19 facts ▸
  • Board meeting, 26/03/2024
  • General meeting, 30/04/2024
  • Director resignation, Daniel O'Day (director)
  • Director appointment, Andrew Dickinson (non-executive director)
  • Mandate compensation, Andrew Dickinson
  • Director reappointment, Elisabeth Svanberg (onafhankelijk niet uitvoerend lid van de raad van bestuur)
  • Mandate compensation, Elisabeth Svanberg
  • Director appointment, Susanne Schaffert (onafhankelijk niet uitvoerend lid van de raad van bestuur)
  • Mandate compensation, Susanne Schaffert
  • Director appointment, Simon Sturge (onafhankelijk niet uitvoerend lid van de raad van bestuur)
  • Mandate compensation, Simon Sturge
  • Mandate compensation, Galapagos NV
  • +7 further facts in this act
20-06
NBB filing Annual accounts filed
fiscal year 2023 · full schema
29-05
State Gazette act Miscellaneous
24-05
State Gazette act Miscellaneous
07-05
State Gazette act Statutes amendment
Share issue · Waiver of preemptive rights4 facts ▸
  • General meeting, 30 april 2024
  • Share issue, uitgifte van één (1) nieuw inschrijvingsrecht (in de vorm van een warrant) aan Gilead Therapeutics, de 'Subsequent Gilead Warrant B' genaamd
  • Statutes amendment
  • Waiver of preemptive rights, Waiver of statutory pre-emptive rights of existing shareholders in favor of Gilead Therapeutics A1 Unlimited Company for the issuance of the 'Subsequent Gilead…
21-02
State Gazette act Appointment: BDO Bedrijfsrevisoren BV (statutory auditor)
Permanent representative: Ellen Lombaerts3 facts ▸
  • General meeting, 25/04/2023
  • Auditor appointment, BDO Bedrijfsrevisoren BV (statutory auditor)
  • Permanent representative, Ellen Lombaerts
30-01
State Gazette act Miscellaneous
29-01
State Gazette act Resignation: Michele Manto (lid van het directiecomité als chief commercial officer)
Appointments: Stoffels IMC BV, Thad Hudson and 10 others · Permanent representative: Dr. Paul Stoffels16 facts ▸
  • Board meeting, 11/12/2023
  • Director resignation, Michele Manto (lid van het directiecomité als chief commercial officer)
  • Director appointment, Stoffels IMC BV (lid van het directiecomité als chief executive officer)
  • Permanent representative, Dr. Paul Stoffels
  • Director appointment, Thad Hudson (lid van het directiecomité als chief operating officer en chief financial officer)
  • Director appointment, Annelies Missotten (lid van het directiecomité als chief human resources officer)
  • Director appointment, Valeria Cnossen (lid van het directiecomité als general counsel)
  • Director appointment, Stoffels IMC BV (bestuurder als voorzitter van de raad van bestuur)
  • Director appointment, Linda Higgins (director)
  • Director appointment, Daniel O'Day (director)
  • Director appointment, Dan G. Baker (independent director)
  • Director appointment, Jérôme Contamine (independent director)
  • +4 further facts in this act
2023
31-12
Financial Back to profitnet €271.3m
Net result €271.3m after 2 loss-making years.
13-11
State Gazette act Resignation: Mary Kerr (independent director)
Appointments: Simon Sturge, Paul Stoffels and 11 others · Permanent representative: Paul Stoffels18 facts ▸
  • Board meeting, 19/09/2023
  • Director resignation, Mary Kerr (independent director)
  • Director appointment, Simon Sturge (niet uitvoerende onafhankelijke bestuurder)
  • Permanent representative, Paul Stoffels
  • Director appointment, Paul Stoffels (chief executive officer)
  • Director appointment, Thad Hudson (chief operating officer en chief financial officer)
  • Director appointment, Michele Manto (chief commercial officer)
  • Director appointment, Annelies Missotten (chief human resources officer)
  • Director appointment, Valeria Cnossen (general counsel)
  • Director appointment, Paul Stoffels (chair of the board)
  • Director appointment, Linda Higgins (director)
  • Director appointment, Daniel O'Day (director)
  • +6 further facts in this act
31-08
State Gazette act Miscellaneous
Share issue1 fact ▸
  • Share issue, Vaststelling van de aanvaarding van 50.000 inschrijvingsrechten (Inschrijvingsrechtenplan 2023 BE, aanbod 5 mei 2023) en 200.000 inschrijvingsrechten (Inschrijv…
23-08
State Gazette act Resignations: Bart Fllius (lid van het directiecomité als president, chief operating officer en chief financial officer) and Dr. Rajesh Parekh (director)
Appointments: Dr. Susanne Schaffert, Thad Huston and 11 others · Permanent representative: Dr. Paul Stoffels19 facts ▸
  • Board meeting, 02/05/2023
  • Director resignation, Bart Fllius (lid van het directiecomité als president, chief operating officer en chief financial officer)
  • Board meeting, 12/06/2023
  • Director resignation, Dr. Rajesh Parekh (director)
  • Director appointment, Dr. Susanne Schaffert (niet uitvoerende onafhankelijke bestuurder)
  • Director appointment, Thad Huston (lid van het directiecomité als chief operating officer en chief financial officer)
  • Permanent representative, Dr. Paul Stoffels
  • Director appointment, Dr. Paul Stoffels (chair of the board)
  • Director appointment, Michele Manto (chief commercial officer)
  • Director appointment, Annelies Missotten (chief human resources officer)
  • Director appointment, Valeria Cnossen (general counsel)
  • Director appointment, Linda Higgins (director)
  • +7 further facts in this act
13-07
State Gazette act Miscellaneous
Share issue2 facts ▸
  • Share issue, Vaststelling van de aanvaarding van inschrijvingsrechten en verwezenlijking van de opschortende voorwaarde
  • Share issue, Tweede vaststelling van de uitgifte van inschrijvingsrechten binnen het toegestaan kapitaal
17-05
State Gazette act Miscellaneous
17-05
State Gazette act Miscellaneous
15-05
State Gazette act Resignations: André Hoekema (member of the executive committee) and Walid Abi-Saab (member of the executive committee)
Appointments: Annelies Missotten (lid van het directiecomité als chief human resources officer) and Valeria Cnossen (lid van het directiecomité als general counsel) · Reappointments: Peter Guenter, Daniel O'Day and Dr. Linda Higgins · Permanent representative: Dr. Paul Stoffels14 facts ▸
  • Board meeting, 19/09/2022
  • Director resignation, André Hoekema (member of the executive committee)
  • Director resignation, Walid Abi-Saab (member of the executive committee)
  • Board meeting, 09/12/2022
  • Director appointment, Annelies Missotten (lid van het directiecomité als chief human resources officer)
  • Director appointment, Valeria Cnossen (lid van het directiecomité als general counsel)
  • General meeting, 25/04/2023
  • Director reappointment, Peter Guenter (onafhankelijk lid van de raad van bestuur)
  • Mandate compensation, Peter Guenter
  • Director reappointment, Daniel O'Day (niet onafhankelijk lid van de raad van bestuur)
  • Mandate compensation, Daniel O'Day
  • Director reappointment, Dr. Linda Higgins (niet onafhankelijk lid van de raad van bestuur)
  • +2 further facts in this act
12-05
NBB filing Annual accounts filed
fiscal year 2022 · full schema
11-05
NBB filing Annual accounts filed
fiscal year 2022 · consolidated
10-05
State Gazette act Miscellaneous
23-03
State Gazette act Capital & shares
Capital · Statutes amendment2 facts ▸
  • Capital, €356.444.938,61
  • Statutes amendment
2022
17-11
State Gazette act Miscellaneous
03-10
State Gazette act Capital & shares
Capital · Statutes amendment2 facts ▸
  • Capital, €356.111.899,01
  • Statutes amendment
22-09
State Gazette act Resignations & appointments
Board meeting1 fact ▸
  • Board meeting, 01/09/2022
09-09
State Gazette act Miscellaneous
22-07
State Gazette act Miscellaneous
14-07
State Gazette act Resignations & appointments
Share issue2 facts ▸
  • Board meeting, 06/05/2022
  • Share issue, Uitgifte van inschrijvingsrechten binnen het toegestaan kapitaal
30-06
State Gazette act Resignation: Onno van de Stolpe (lid van de directieraad en ceo)
Appointments: Stoffels IMC BV, Bart Filius and 3 others · Permanent representative: Paulus Stoffels11 facts ▸
  • Board meeting, 22/03/2022
  • Board meeting, 26/04/2022
  • Director resignation, Onno van de Stolpe (lid van de directieraad en ceo)
  • Director appointment, Stoffels IMC BV (member of the management board)
  • Director appointment, Stoffels IMC BV (ceo)
  • Permanent representative, Paulus Stoffels
  • Director appointment, Stoffels IMC BV (ceo)
  • Director appointment, Bart Filius (president, coo & cfo)
  • Director appointment, Andreas Hoekema (cbo)
  • Director appointment, Walid Abi-Saab (cmo)
  • Director appointment, Michele Manto (cco)
24-06
State Gazette act Capital & shares
Capital · Statutes amendment2 facts ▸
  • Capital, €355.533.029,01
  • Statutes amendment
27-05
State Gazette act Appointments: Dr. Raj Parekh, Dr. Mary Kerr and 9 others
Permanent representative: Paul Stoffels · Statutes amendment · Approval22 facts ▸
  • General meeting, 26/04/2022
  • Statutes amendment
  • Director appointment, Dr. Raj Parekh (director)
  • Director appointment, Dr. Mary Kerr (onafhankelijk lid van de raad van bestuur)
  • Director appointment, Mw. Katrine Bosley (onafhankelijk lid van de raad van bestuur)
  • Director appointment, Dhr. Peter Guenter (onafhankelijk lid van de raad van bestuur)
  • Director appointment, Dhr. Daniel O'Day (director)
  • Director appointment, Dhr. Howard Rowe (onafhankelijk lid van de raad van bestuur)
  • Director appointment, Dr. Linda Higgins (director)
  • Director appointment, Dr. Elisabeth Svanberg (onafhankelijk lid van de raad van bestuur)
  • General meeting, 26/04/2022
  • Approval, Goedkeuring statutaire jaarrekening boekjaar geëindigd 31 december 2021 en bestemming jaarresultaat.
  • +10 further facts in this act
29-04
NBB filing Annual accounts filed
fiscal year 2021 · full schema
29-04
NBB filing Annual accounts filed
fiscal year 2021 · consolidated
05-04
State Gazette act Miscellaneous
24-03
State Gazette act Capital & shares · Statutes amendment
Capital increase · Share issue · Bank account5 facts ▸
  • Capital increase, €2.159.600
  • Share issue, gedematerialiseerde aandelen, 95500
  • Bank account, KBC Bank NV, BE41 7330 0933 9110
  • Capital, €355.098.660,11
  • Statutes amendment
08-03
State Gazette act Resignation: Piet Wigerinck (lid van de directieraad en cso)
Appointment: Bart Filius (president & coo)4 facts ▸
  • Board meeting, 14/12/2021
  • Director resignation, Piet Wigerinck (lid van de directieraad en cso)
  • Board meeting, 15/02/2021
  • Director appointment, Bart Filius (president & coo)
01-02
State Gazette act Miscellaneous
Share issue · Power of attorney · Waiver of preemptive rights6 facts ▸
  • Board meeting, 26 januari 2022
  • Share issue, Inschrijvingsrechtenplan 2022 (B), inschrijvingsrechten
  • Power of attorney, Marie-Théodora VANDEWIELE
  • Power of attorney, Annelies DENECKER
  • Power of attorney, Marie-Théodora VANDEWIELE
  • Waiver of preemptive rights, opheffing van het voorkeurrecht van de bestaande aandeelhouders in het kader van de uitgifte van de Inschrijvingsrechten 2022 (B) en de daarmee verbonden kapita…
20-01
State Gazette act Miscellaneous
Share issue1 fact ▸
  • Share issue, Inschrijvingsrechtenplan 2022 (A), inschrijvingsrechten
19-01
State Gazette act Miscellaneous
Share issue · Power of attorney · Waiver of preemptive rights5 facts ▸
  • Board meeting, 13 januari 2022
  • Share issue, Inschrijvingsrechtenplan 2022 (A), inschrijvingsrechten
  • Power of attorney, elk lid van de Raad van Toezicht, elk lid van de Directieraad, mevrouw Marie-Théodora Vandewiele, mevrouw Annelies Denecker, mevrouw Smitha Van den Acker, mevrouw Elien Van Mol, mevrouw Laura Mylemans, mevrouw Lauran Diependaele, mevrouw Klaartje Konings
  • Power of attorney, elk lid van de Raad van Toezicht, elk lid van de Directieraad, General Counsel mevrouw Marie-Théodora Vandewiele
  • Waiver of preemptive rights, opheffing van het voorkeurrecht van de bestaande aandeelhouders in het kader van de uitgifte van de Inschrijvingsrechten 2022 (A) en de daarmee verbonden kapita…
2021
09-12
State Gazette act Capital & shares
Capital · Statutes amendment2 facts ▸
  • Capital, €354.582.005,11
  • Statutes amendment
24-09
State Gazette act Capital & shares · Statutes amendment
Capital1 fact ▸
  • Capital, €354.459.739,11
24-08
State Gazette act Miscellaneous
Share issue1 fact ▸
  • Share issue, Inschrijvingsrechtenplan 2021 BE, inschrijvingsrechten
08-07
State Gazette act Miscellaneous
Share issue1 fact ▸
  • Share issue, Vastelling aanvaarding van inschrijvingsrechten en vaststelling uitgifte van inschrijvingsrechten binnen het toegestaan kapitaal
17-06
State Gazette act Reappointments: Katrine Bosley (onafhankelijk lid van de raad van toezicht) and Raj Parekh (lid van de raad van toezicht)
Mandate compensation5 facts ▸
  • General meeting, 28/04/2021
  • Director reappointment, Katrine Bosley (onafhankelijk lid van de raad van toezicht)
  • Director reappointment, Raj Parekh (lid van de raad van toezicht)
  • Mandate compensation, Katrine Bosley
  • Mandate compensation, Raj Parekh
10-06
State Gazette act Capital & shares
Capital · Statutes amendment2 facts ▸
  • Capital, €354.418.623,11
  • Statutes amendment
01-06
State Gazette act Miscellaneous
Share issue2 facts ▸
  • Board meeting, 30/04/2021
  • Share issue, Uitgifte van inschrijvingsrechten binnen het toegestaan kapitaal
25-03
State Gazette act Capital & shares
Capital · Statutes amendment2 facts ▸
  • Capital, €354.359.437,71
  • Statutes amendment
2020
31-12
Financial Weakest financial yearnet -€196.0m
Net result drops to -€196.0m, the lowest in the series; recovery starts the following year.
16-12
State Gazette act Capital & shares · Miscellaneous
Share issue1 fact ▸
  • Share issue, inschrijvingsrechten uitgegeven binnen het toegestaan kapitaal onder het Inschrijvingsrechtenplan 2020 RMV
11-12
State Gazette act Capital & shares · Statutes amendment
Capital2 facts ▸
  • Capital, €353.819.443,97
  • Statutes amendment
29-09
State Gazette act Capital & shares · Statutes amendment
Capital1 fact ▸
  • Capital, €353.435.739,72
04-09
State Gazette act Resignation: Onno van de Stolpe (director)
Appointments: Onno van de Stolpe, Bart Filius and 4 others8 facts ▸
  • Board meeting, 28/04/2020
  • Director resignation, Onno van de Stolpe (director)
  • Director appointment, Onno van de Stolpe (lid van de directieraad, voorzitter en chief executive officer)
  • Director appointment, Bart Filius (lid van de directieraad, chief operating officer en chief financial officer)
  • Director appointment, Andre Hoekema (lid van de directieraad, chief business officer)
  • Director appointment, Piet Wigerinck (lid van de directieraad, chief scientific officer)
  • Director appointment, Walid Abi-Saab (lid van de directieraad, chief medical officer)
  • Director appointment, Michele Manto (lid van de directieraad, chief commercial officer)
15-07
State Gazette act Appointment: Michele Manto (member of the management board)
3 facts ▸
  • Board meeting, 28-04-2020
  • Director appointment, Michele Manto (member of the management board)
  • Director appointment, Michele Manto (member of the executive committee)
08-06
State Gazette act Capital & shares · Resignations & appointments
Capital1 fact ▸
  • Capital, €352.968.964,92
11-05
State Gazette act Appointments: Deloitte Bedrijfsrevisoren CVBA, Dr. Elisabeth Svanberg and 7 others
Reappointment: Dr. Mary Kerr (director) · Director discharge · Share issue17 facts ▸
  • General meeting, 28 april 2020
  • Director discharge, GALAPAGOS
  • Auditor appointment, Deloitte Bedrijfsrevisoren CVBA (statutory auditor)
  • Director reappointment, Dr. Mary Kerr (director)
  • Director appointment, Dr. Elisabeth Svanberg (director)
  • Share issue, inschrijvingsrechten, 85000
  • Purpose change, De vennootschap heeft tot voorwerp: 1. het onderzoek en de ontwikkeling van gezondheidsproducten voor mens en dier, geneesmiddelen en andere daarmee verband hou…
  • Statutes amendment
  • Director appointment, Dr. Raj Parekh (lid van de raad van toezicht)
  • Director appointment, Howard Rowe (lid van de raad van toezicht)
  • Director appointment, Katrine Bosley (lid van de raad van toezicht)
  • Director appointment, Dr. Mary Kerr (lid van de raad van toezicht)
  • +5 further facts in this act
24-04
State Gazette act Miscellaneous
Share issue · Power of attorney7 facts ▸
  • Board meeting, 17 april 2020
  • Share issue, uitgifte van maximaal 2.280.500 inschrijvingsrechten ten behoeve van personeelsleden
  • Power of attorney, Xavier Maes
  • Power of attorney, Ellen Lefever
  • Power of attorney, Annelies Denecker
  • Power of attorney, Smitha Van den Acker
  • Power of attorney, Xavier Maes
25-03
State Gazette act Capital & shares
Capital · Statutes amendment2 facts ▸
  • Capital, €350.612.693,52
  • Statutes amendment
2019
31-12
Financial Back to profitnet €379.0m
Net result €379.0m after one loss-making year.
31-12
Financial Liquidity triplescurrent ratio 24.73
Current ratio from 9.46 to 24.73.
31-12
Financial Equity above €2.5bnEq €2.90bn ▲147%
Equity rises from €1.17bn to €2.90bn.
20-12
State Gazette act Capital & shares · Statutes amendment
Capital1 fact ▸
  • Capital, euro 349.789.183,32
13-11
State Gazette act Appointments: Daniel O'Day (niet onafhankelijke bestuurder) and Linda Higgins (niet onafhankelijke bestuurder)
Share issue · Statutes amendment · Mandate compensation7 facts ▸
  • General meeting, 22-10-2019
  • Share issue, uitgifte van twee warrants aan Gilead Therapeutics, de 'Initiële Warrant A' en de 'Initiële Warrant B' genaamd
  • Statutes amendment
  • Director appointment, Daniel O'Day (niet onafhankelijke bestuurder)
  • Mandate compensation, Daniel O'Day
  • Director appointment, Linda Higgins (niet onafhankelijke bestuurder)
  • Mandate compensation, Linda Higgins
07-10
State Gazette act Capital & shares
Capital · Statutes amendment2 facts ▸
  • Capital, euro 335.112.010,21
  • Statutes amendment
06-09
State Gazette act Capital & shares
Capital increase · Capital · Statutes amendment6 facts ▸
  • Board meeting, 23 augustus 2019
  • Capital increase, €333.479.569,76
  • Capital, €333.479.569,76
  • Statutes amendment
  • Power of attorney, Xavier MAES
  • Power of attorney, Damien HISETTE
21-08
State Gazette act Capital & shares
03-07
State Gazette act Capital & shares
Capital1 fact ▸
  • Capital, euro 296.534.760,91
22-05
State Gazette act Miscellaneous
General meeting1 fact ▸
  • General meeting, 30/04/2019
22-05
State Gazette act Appointments: Peter Guenter, Howard Rowe and 8 others
Director discharge14 facts ▸
  • General meeting, 30/04/2019
  • Director discharge, Harrold van Barlingen
  • Director discharge, Galapagos NV
  • Director appointment, Peter Guenter (director)
  • Director appointment, Howard Rowe (independent director)
  • Director appointment, Raj Parekh (chair)
  • Director appointment, Onno van de Stolpe (managing director)
  • Director appointment, Katrine Bosley (independent director)
  • Director appointment, Mary Kerr (independent director)
  • Director appointment, Onno van de Stolpe (chief executive officer)
  • Director appointment, Piet Wigerinck (chief scientific officer)
  • Director appointment, Bart Filius (chief operating officer en chief financial officer)
  • +2 further facts in this act
13-05
State Gazette act Miscellaneous
Share issue2 facts ▸
  • Board meeting, 10/04/2019
  • Share issue, Uitgifte van warrants binnen het toegestaan kapitaal
16-04
State Gazette act Capital & shares
Capital · Statutes amendment2 facts ▸
  • Capital, euro 295.407.803,81
  • Statutes amendment
15-04
State Gazette act Algemene Vergadering
2018
05-12
State Gazette act Capital & shares
Capital · Statutes amendment2 facts ▸
  • Capital, €294.599.712,11
  • Statutes amendment
24-10
State Gazette act Capital & shares
Capital increase · Statutes amendment2 facts ▸
  • Capital increase, euro 294.433.084,11
  • Statutes amendment
17-10
State Gazette act Resignations & appointments
Capital increase · Subscription period opening3 facts ▸
  • Board meeting
  • Capital increase
  • Subscription period opening
17-10
State Gazette act Capital & shares
Capital increase · Capital · Statutes amendment3 facts ▸
  • Capital increase, €293.700.110,26
  • Capital, €293.700.110,26
  • Statutes amendment
14-09
State Gazette act Capital & shares
Warrant issue1 fact ▸
  • Warrant issue, Vaststelling aanvaarding en uitgifte van warrants binnen het toegestaan kapitaal
20-07
State Gazette act Capital & shares
Capital increase · Capital · Statutes amendment3 facts ▸
  • Capital increase, €277.679.082,33
  • Capital, €277.679.082,33
  • Statutes amendment
30-05
State Gazette act Capital & shares
Share issue2 facts ▸
  • Board meeting, 19/04/2018
  • Share issue, Uitgifte van warrants binnen het toegestaan kapitaal
23-05
State Gazette act Miscellaneous
General meeting1 fact ▸
  • General meeting, 24/04/2018
23-05
State Gazette act Reappointments: Werner Cautreels (director) and Howard Rowe (director)
Appointment: Howard Rowe (independent director) · Director discharge5 facts ▸
  • General meeting, 24-04-2018
  • Director discharge, Galapagos NV
  • Director reappointment, Werner Cautreels (director)
  • Director reappointment, Howard Rowe (director)
  • Director appointment, Howard Rowe (independent director)
12-04
State Gazette act Capital & shares
Capital increase · Capital · Warrant exercise4 facts ▸
  • Capital increase, €277.122.928,92
  • Capital, €277.122.928,92
  • Warrant exercise, confirmed
  • Statutes amendment
11-01
State Gazette act Capital & shares · Statutes amendment
Capital increase · Capital3 facts ▸
  • Capital increase, €275.509.753,48
  • Capital, €275.509.753,48
  • Statutes amendment
2017
17-10
State Gazette act Capital & shares · Statutes amendment
Capital increase · Capital2 facts ▸
  • Capital increase, €275.287.943,48
  • Capital, €275.287.943,48
19-09
State Gazette act Capital & shares
20-07
State Gazette act Capital & shares
Capital increase · Statutes amendment2 facts ▸
  • Capital increase, €275.135.922,48
  • Statutes amendment
16-06
State Gazette act Capital & shares
Share issue2 facts ▸
  • Board meeting, 17/05/2017
  • Share issue, Uitgifte van warrants binnen het toegestaan kapitaal
13-06
State Gazette act Resignations & appointments
General meeting1 fact ▸
  • General meeting, 25/04/2017
13-06
State Gazette act Appointments: Deloitte Bedrijfsrevisoren BV o.v.v.e. CVBA, Katrine Bosley and 2 others
Reappointments: Onno van de Stolpe, Raj Parekh and Katrine Bosley · Director discharge9 facts ▸
  • General meeting, 25/04/2017
  • Director discharge, Galapagos NV
  • Auditor appointment, Deloitte Bedrijfsrevisoren BV o.v.v.e. CVBA (statutory auditor)
  • Director reappointment, Onno van de Stolpe (director)
  • Director reappointment, Raj Parekh (director)
  • Director reappointment, Katrine Bosley (director)
  • Director appointment, Katrine Bosley (independent director)
  • Director appointment, Raj Parekh (chair)
  • Director appointment, Onno van de Stolpe (gedelegeerd bestuurder, ceo)
13-06
State Gazette act Appointment: Walid Abi-Saab (member of the executive committee)
2 facts ▸
  • Director appointment, Walid Abi-Saab (member of the executive committee)
  • Director appointment, Walid Abi-Saab (chief medical officer)
31-05
State Gazette act Capital & shares · Statutes amendment · Resignations & appointments
3 facts ▸
  • General meeting, 25/04/2017
  • Statutes amendment
  • Statutes amendment
12-05
State Gazette act Capital & shares
Capital increase · Share issue · Power of attorney4 facts ▸
  • Board meeting, 17/04/2017
  • Capital increase
  • Share issue, Besluit tot openstelling van de inschrijvingsperiode
  • Power of attorney, GALAPAGOS
12-05
State Gazette act Capital & shares · Statutes amendment
Capital increase · Capital · Power of attorney4 facts ▸
  • Capital increase
  • Capital, €274.854.440,18
  • Statutes amendment
  • Power of attorney, Matthieu DERYNCK
04-05
State Gazette act Capital & shares
Capital increase · Statutes amendment2 facts ▸
  • Capital increase, €251.523.815,18
  • Statutes amendment
04-05
State Gazette act Miscellaneous
Share issue1 fact ▸
  • Share issue, Vaststelling aanvaarding van warrants - Vaststelling uitgifte van warrants binnen het toegestaan kapitaal
21-02
State Gazette act Capital & shares
Share issue2 facts ▸
  • Board meeting, 20/01/2017
  • Share issue, Uitgifte van warrants binnen het toegestaan kapitaal
10-01
State Gazette act Capital & shares · Resignations & appointments
Capital increase · Capital · Statutes amendment3 facts ▸
  • Capital increase, €250.187.166,48
  • Capital, €250.187.166,48
  • Statutes amendment
2016
07-10
State Gazette act Capital & shares
Capital increase · Capital · Statutes amendment3 facts ▸
  • Capital increase, €249.720.553,98
  • Capital, €249.720.553,98
  • Statutes amendment
01-09
State Gazette act Algemene Vergadering
25-08
State Gazette act Appointment: Mary Kerr (director)
3 facts ▸
  • General meeting, 26/07/2016
  • Director appointment, Mary Kerr (director)
  • Director appointment, Mary Kerr (independent director)
29-06
State Gazette act Capital & shares
Share issue2 facts ▸
  • Board meeting, 01 juni 2016
  • Share issue, Uitgifte van warrants binnen het toegestaan kapitaal
16-06
State Gazette act Capital & shares
Capital increase · Capital2 facts ▸
  • Capital increase, €249.394.222,78
  • Capital, €249.394.222,78
03-06
State Gazette act Capital & shares
Statutes amendment · Authorization duration3 facts ▸
  • General meeting, 26/04/2016
  • Statutes amendment
  • Authorization duration, 5 years from publication date
17-05
State Gazette act Capital & shares
General meeting2 facts ▸
  • General meeting, 22/12/2015
  • General meeting, 26/04/2016
17-05
State Gazette act Capital & shares
Power of attorney2 facts ▸
  • Board meeting, 23/06/2015
  • Power of attorney, alle leden van het directiecomite en personen met de titel Vice President of Site Head
28-04
State Gazette act Capital & shares
Capital increase1 fact ▸
  • Capital increase, €248.632.657,08
15-04
State Gazette act Capital & shares
Share issue1 fact ▸
  • Share issue, Vaststelling aanvaarding van warrants - Vaststelling uitgifte van warrants binnen het toegestaan kapitaal
09-02
State Gazette act Capital & shares
Capital increase · Capital · Statutes amendment6 facts ▸
  • Board meeting, 19/01/2016
  • Capital increase, €36.575.392,41
  • Capital, €247.964.249,63
  • Statutes amendment
  • Power of attorney, Damien HISETTE
  • Waiver of preemptive rights, ja
01-02
State Gazette act Capital & shares
Share issue2 facts ▸
  • Board meeting, 21/12/2015
  • Share issue, Uitgifte van warrants binnen het toegestaan kapitaal
13-01
State Gazette act Capital & shares
Capital increase · Statutes amendment2 facts ▸
  • Capital increase, €211.388.857,22
  • Statutes amendment
05-01
State Gazette act Appointment: Dr. Christine Mummery (director)
4 facts ▸
  • Board meeting, 30/09/2015
  • General meeting, 22/12/2015
  • Director appointment, Dr. Christine Mummery (director)
  • Director appointment, Dr. Christine Mummery (independent director)
2015
12-11
State Gazette act Capital & shares · Statutes amendment
Capital2 facts ▸
  • Capital, €211.045.322,22
  • Statutes amendment
04-08
State Gazette act Capital & shares
Warrant issue1 fact ▸
  • Warrant issue, Vaststelling aanvaarding van warrants - Vaststelling uitgifte van warrants binnen het toegestaan kapitaal
15-07
State Gazette act Capital & shares · Statutes amendment
Capital increase2 facts ▸
  • Capital increase, €210.405.535,62
  • Statutes amendment
25-06
State Gazette act Capital & shares
Capital increase · Capital · Statutes amendment3 facts ▸
  • Capital increase, €207.747.029,16
  • Capital, €207.747.029,16
  • Statutes amendment
25-06
State Gazette act Resignation: Vicki Sato (director)
Appointment: Deloitte Bedrijfsrevisoren (statutory auditor) · Director discharge5 facts ▸
  • General meeting, 28 april 2015
  • Director discharge, Galapagos NV
  • Director discharge, Vicki Sato
  • Director resignation, Vicki Sato (director)
  • Auditor appointment, Deloitte Bedrijfsrevisoren (statutory auditor)
25-06
State Gazette act Miscellaneous
General meeting1 fact ▸
  • General meeting, 28/04/2015
11-06
State Gazette act Capital & shares
Capital increase2 facts ▸
  • Board meeting, 13/05/2015
  • Capital increase
02-06
State Gazette act Miscellaneous
Capital increase · Share issue3 facts ▸
  • Board meeting, 05/05/2015
  • Capital increase
  • Share issue, Besluit tot openstelling van de inschrijvingsperiode
01-06
State Gazette act Miscellaneous
Share issue2 facts ▸
  • Board meeting, 30/04/2015
  • Share issue, Uitgifte van warrants binnen het toegestaan kapitaal
06-05
State Gazette act Capital & shares
Capital increase · Statutes amendment2 facts ▸
  • Capital increase, €166.996.209,57
  • Statutes amendment
06-02
State Gazette act Resignation: Vicki Sato (director)
Appointments: Raj Parekh, Onno van de Stolpe and 7 others11 facts ▸
  • Director resignation, Vicki Sato (director)
  • Director appointment, Raj Parekh (chair)
  • Director appointment, Onno van de Stolpe (gedelegeerd bestuurder, ceo)
  • Director appointment, Katrine Bosley (independent director)
  • Director appointment, Henricus van Barlingen (director)
  • Director appointment, Werner Cautreels (independent director)
  • Director appointment, Howard Rowe (independent director)
  • Director appointment, Bart Filius (lid van het directiecomité, chief financial officer)
  • Director appointment, Onno van de Stolpe (voorzitter directiecomité, chief executive officer)
  • Director appointment, André Hoekema (lid van het directiecomité, senior vice president corporate development)
  • Director appointment, Piet Wigerinck (lid van het directiecomité, chief scientific officer)
29-01
State Gazette act Capital & shares · Miscellaneous
Share issue1 fact ▸
  • Share issue, Vaststelling aanvaarding van warrants - Vaststelling uitgifte van warrants binnen het toegestaan kapitaal
29-01
State Gazette act Capital & shares · Statutes amendment
Capital increase · Warrant exercise3 facts ▸
  • Capital increase, €163.904.134,89
  • Statutes amendment
  • Warrant exercise, ja
2014
24-11
State Gazette act Miscellaneous
Share issue2 facts ▸
  • Board meeting, 14 oktober 2014
  • Share issue, Uitgifte van warrants binnen het toegestaan kapitaal
24-11
State Gazette act Miscellaneous
Share issue1 fact ▸
  • Share issue, Vaststelling aanvaarding en uitgifte van warrants binnen het toegestaan kapitaal
14-11
State Gazette act Capital & shares
Capital increase · Statutes amendment2 facts ▸
  • Capital increase, €163.868.834,64
  • Statutes amendment
18-09
State Gazette act Miscellaneous
Share issue2 facts ▸
  • Board meeting, 25 juli 2014
  • Share issue, UITGIFTE VAN WARRANTS BINNEN HET TOEGESTAAN KAPITAAL
18-08
State Gazette act Capital & shares · Statutes amendment
Capital increase2 facts ▸
  • Capital increase, €163.802.508,04
  • Statutes amendment
17-06
State Gazette act Reappointments: Henricus (gezegd "Harrold") van Barlingen, Werner Cautreels and 2 others
Appointments: Werner Cautreels, Howard Rowe and Vicki Sato · Resignations: David Smith (member of the executive committee) and Guillaume Jetten (member of the executive committee) · Permanent representatives: Gert Vanhees and Gino Desmet12 facts ▸
  • General meeting, 29/04/2014
  • Director reappointment, Henricus (gezegd "Harrold") van Barlingen (director)
  • Director reappointment, Werner Cautreels (director)
  • Director appointment, Werner Cautreels (independent director)
  • Director reappointment, Howard Rowe (director)
  • Director appointment, Howard Rowe (independent director)
  • Director reappointment, Vicki Sato (director)
  • Director appointment, Vicki Sato (independent director)
  • Director resignation, David Smith (member of the executive committee)
  • Director resignation, Guillaume Jetten (member of the executive committee)
  • Permanent representative, Gert Vanhees
  • Permanent representative, Gino Desmet
04-06
State Gazette act Statutes amendment
Power of attorney9 facts ▸
  • General meeting, 19/05/2014
  • Statutes amendment
  • Statutes amendment
  • Statutes amendment
  • Statutes amendment
  • Statutes amendment
  • Statutes amendment
  • Power of attorney, Xavier Maes
  • Power of attorney, elke Bestuurder
30-05
State Gazette act Capital & shares
Capital increase · Statutes amendment2 facts ▸
  • Capital increase, €162.820.555,17
  • Statutes amendment
03-02
State Gazette act Capital & shares · Statutes amendment
Capital increase · Capital · Warrant exercise4 facts ▸
  • Capital increase, €161.171.635,86
  • Capital, €161.171.635,86
  • Statutes amendment
  • Warrant exercise, ja
2013
13-11
State Gazette act Reappointments: Onno van de Stolpe (director) and Dr. Raj Parekh (director)
Appointments: Katrine Bosley, Dr. Raj Parekh and 2 others · Resignation: Dr. Christopher Newton (member of the executive committee) · Director discharge11 facts ▸
  • General meeting, 30/04/2013
  • Director discharge, GALAPAGOS
  • Director reappointment, Onno van de Stolpe (director)
  • Director reappointment, Dr. Raj Parekh (director)
  • Director appointment, Katrine Bosley (director)
  • Director appointment, Katrine Bosley (independent director)
  • Board meeting, 11/06/2013
  • Director appointment, Dr. Raj Parekh (chair of the board)
  • Director appointment, Onno van de Stolpe (managing director)
  • Director resignation, Dr. Christopher Newton (member of the executive committee)
  • Director appointment, David Smith (member of the executive committee)
08-11
State Gazette act Capital & shares
Share issue1 fact ▸
  • Share issue, Vaststelling aanvaarding en uitgifte van warrants binnen het toegestaan kapitaal
08-11
State Gazette act Capital & shares · Statutes amendment
Capital increase · Warrant exercise2 facts ▸
  • Capital increase, €161.155.270,61
  • Warrant exercise, VASTSTELLING UITOEFENING VAN WARRANTS
05-11
State Gazette act Capital & shares
Board meeting1 fact ▸
  • Board meeting, 18 september 2013
06-09
State Gazette act Algemene Vergadering
Share issue1 fact ▸
  • Share issue, Vaststelling aanvaarding van warrants - Vaststelling uitgifte van warrants binnen het toegestaan kapitaal
24-07
State Gazette act Capital & shares · Statutes amendment
Capital increase1 fact ▸
  • Capital increase, €160.962.030,82
06-06
State Gazette act Miscellaneous
Share issue2 facts ▸
  • Board meeting, 16/05/2013
  • Share issue, Uitgifte van warrants binnen het toegestaan kapitaal
28-05
State Gazette act Capital & shares
Capital increase · Capital · Statutes amendment3 facts ▸
  • Capital increase
  • Capital, €160.474.357,19
  • Statutes amendment
28-05
State Gazette act Capital & shares
Board meeting1 fact ▸
  • Board meeting, 24 april 2013
07-05
State Gazette act Capital & shares
Capital increase · Capital · Warrant exercise3 facts ▸
  • Capital increase, €145.884.501,48
  • Capital, €145.884.501,48
  • Warrant exercise, ja
26-03
State Gazette act Appointments: Deloitte Bedrijfsrevisoren, Katrine Bosley and 10 others
Permanent representative: Gino Desmet · Resignations: Ferdinand Verdonck, Graham Dixon and Radan Spavent · Director discharge20 facts ▸
  • General meeting, 24/04/2012
  • Director discharge, GALAPAGOS
  • Auditor appointment, Deloitte Bedrijfsrevisoren (statutory auditor)
  • Permanent representative, Gino Desmet
  • Board meeting, 06/03/2013
  • Director resignation, Ferdinand Verdonck (director)
  • Director appointment, Katrine Bosley (niet uitvoerend onafhankelijk bestuurder)
  • Director appointment, Raj Parekh (chair)
  • Director appointment, Onno van de Stolpe (gedelegeerd bestuurder, ceo)
  • Director appointment, Harrold van Barlingen (director)
  • Director appointment, Werner Cautreels (independent director)
  • Director appointment, Howard Rowe (independent director)
  • +8 further facts in this act
25-01
State Gazette act Capital & shares · Statutes amendment
Capital increase2 facts ▸
  • Capital increase, €144.815.588,27
  • Statutes amendment
2012
28-11
State Gazette act Capital & shares
03-10
State Gazette act Capital & shares · Statutes amendment
Capital increase2 facts ▸
  • Capital increase, €143.887.102,43
  • Statutes amendment
21-09
State Gazette act Capital & shares
Share issue2 facts ▸
  • Board meeting, 03 september 2012
  • Share issue, UITGIFTE VAN WARRANTS BINNEN HET TOEGESTAAN KAPITAAL
07-09
State Gazette act Capital & shares
01-08
State Gazette act Capital & shares · Statutes amendment
Capital increase2 facts ▸
  • Capital increase, €143.770.414,14
  • Statutes amendment
04-06
State Gazette act Statutes amendment
Power of attorney12 facts ▸
  • General meeting, 16 mei 2012
  • Statutes amendment
  • Statutes amendment
  • Statutes amendment
  • Statutes amendment
  • Statutes amendment
  • Statutes amendment
  • Statutes amendment
  • Statutes amendment
  • Statutes amendment
  • Statutes amendment
  • Power of attorney, elke bestuurder en/of de bedrijfsjurist, elke Belgische notaris
14-05
State Gazette act Capital & shares · Statutes amendment
Capital increase · Capital3 facts ▸
  • Capital increase, €143.669.252,55
  • Capital, €143.669.252,55
  • Statutes amendment
17-01
State Gazette act Capital & shares · Statutes amendment
Capital increase2 facts ▸
  • Capital increase, €142.928.662,81
  • Statutes amendment
2011
12-08
State Gazette act Resignations & appointments
12-08
State Gazette act Resignations & appointments
Share issue1 fact ▸
  • Share issue, Vaststelling aanvaarding van warrants - Vaststelling uitgifte van warrants binnen het toegestaan kapitaal
05-08
State Gazette act Capital & shares · Statutes amendment
Capital increase · Power of attorney3 facts ▸
  • Capital increase, €142.920.142,06
  • Statutes amendment
  • Power of attorney, Damien HISETTE
27-07
State Gazette act Appointments: Howard Rowe, Vicki Sato and 5 others
Resignation: Ronald Brus (director) · Director discharge11 facts ▸
  • General meeting, 26 april 2011
  • Director appointment, Howard Rowe (independent director)
  • Director appointment, Vicki Sato (independent director)
  • Director discharge, GALAPAGOS
  • Board meeting, 25 mei 2011
  • Director resignation, Ronald Brus (director)
  • Director appointment, Raj Parekh (chair)
  • Director appointment, Onno van de Stolpe (gedelegeerd bestuurder, ceo)
  • Director appointment, Ferdinand Verdonck (independent director)
  • Director appointment, Harrold van Barlingen (director)
  • Director appointment, Werner Cautreels (independent director)
10-06
State Gazette act Miscellaneous
Share issue2 facts ▸
  • Board meeting, 23 mei 2011
  • Share issue, Uitgifte van warrants binnen het toegestaan kapitaal
10-06
State Gazette act Capital & shares · Statutes amendment
Power of attorney6 facts ▸
  • General meeting, 23 mei 2011
  • Statutes amendment
  • Statutes amendment
  • Statutes amendment
  • Power of attorney, Johan Van den Eynde
  • Power of attorney, Marc DE BACKER
27-04
State Gazette act Capital & shares
Capital increase · Statutes amendment2 facts ▸
  • Capital increase, €142.874.773,8
  • Statutes amendment
18-02
State Gazette act Capital & shares
Share issue1 fact ▸
  • Share issue, Vaststelling uitgifte van warrants binnen het toegestaan kapitaal
31-01
State Gazette act Capital & shares · Resignations & appointments
Share issue2 facts ▸
  • Board meeting, 23 december 2010
  • Share issue, UITGIFTE VAN WARRANTS BINNEN HET TOEGESTAAN KAPITAAL
2010
31-12
State Gazette act Capital & shares · Statutes amendment
Capital increase2 facts ▸
  • Capital increase, €142.590.770,44
  • Statutes amendment
19-11
State Gazette act Capital & shares
Capital increase · Capital · Statutes amendment3 facts ▸
  • Capital increase, €142.178.761,07
  • Capital, €142.178.761,07
  • Statutes amendment
09-11
State Gazette act Capital & shares
Capital increase · Power of attorney3 facts ▸
  • Board meeting, 19 oktober 2010
  • Capital increase
  • Power of attorney, GALAPAGOS
26-10
State Gazette act Appointments: Howard Rowe (independent director) and Radan Spaventi (member of the executive committee)
Resignation: Rapeport (director)5 facts ▸
  • Board meeting, 05/08/2010
  • Director appointment, Howard Rowe (independent director)
  • Director resignation, Rapeport (director)
  • Board meeting, 24/09/2010
  • Director appointment, Radan Spaventi (member of the executive committee)
04-10
State Gazette act Capital & shares · Statutes amendment
Capital increase2 facts ▸
  • Capital increase, €129.252.393,8
  • Statutes amendment
16-08
State Gazette act Resignations: Wilson Totten, David Stone and 5 others
Appointments: Rudi Pauwels, Garth Rapeport and 9 others · Reappointments: Raj Parekh, Onno van de Stolpe and 3 others · Director discharge25 facts ▸
  • Director resignation, Wilson Totten (director)
  • Director resignation, David Stone (director)
  • Director resignation, Geoff McMillan (director)
  • Director appointment, Rudi Pauwels (independent director)
  • Director resignation, Rudi Pauwels (independent director)
  • Director resignation, Barry Ross (director)
  • Director appointment, Garth Rapeport (independent director)
  • Director resignation, Garth Rapeport (independent director)
  • Director reappointment, Raj Parekh (director)
  • Director reappointment, Onno van de Stolpe (director)
  • Director reappointment, Ferdinand Verdonck (independent director)
  • Director resignation, Laurent Ganem (director)
  • +13 further facts in this act
06-08
State Gazette act Capital & shares · Miscellaneous
06-08
State Gazette act Capital & shares · Miscellaneous
Share issue1 fact ▸
  • Share issue, Vaststelling uitgifte van warrants binnen het toegestaan kapitaal
20-07
State Gazette act Capital & shares · Statutes amendment
Capital increase · Capital3 facts ▸
  • Capital increase, €129.233.772,58
  • Capital, €129.233.772,58
  • Statutes amendment
12-05
State Gazette act Capital & shares · Resignations & appointments
Share issue2 facts ▸
  • Board meeting, 27 april 2010
  • Share issue, UITGIFTE VAN WARRANTS BINNEN HET TOEGESTAAN KAPITAAL
12-05
State Gazette act Capital & shares · Resignations & appointments
04-05
State Gazette act Capital & shares
Capital increase · Statutes amendment2 facts ▸
  • Capital increase, €129.016.506,98
  • Statutes amendment
05-01
State Gazette act Capital & shares · Statutes amendment
Capital increase2 facts ▸
  • Capital increase, €127.723.203,2
  • Statutes amendment
2009
30-11
State Gazette act Capital & shares
Capital · Statutes amendment · Power of attorney4 facts ▸
  • Board meeting, 31 oktober 2009
  • Capital, €126.820.639,2
  • Statutes amendment
  • Power of attorney, Jonan Van den Eynde
30-09
State Gazette act Capital & shares
Capital increase · Statutes amendment2 facts ▸
  • Capital increase, €115.276.866,45
  • Statutes amendment
04-05
State Gazette act Capital & shares · Miscellaneous
Share issue2 facts ▸
  • Board meeting, 01/04/2009
  • Share issue, UITGIFTE VAN WARRANTS BINNEN HET TOEGESTAAN KAPITAAL
04-05
State Gazette act Capital & shares · Statutes amendment
Capital increase2 facts ▸
  • Capital increase, €115.068.666,45
  • Statutes amendment
2008
13-10
State Gazette act Capital & shares · Miscellaneous
Share issue1 fact ▸
  • Share issue, Vaststelling uitgifte van warrants binnen het toegestaan kapitaal
2007
26-07
State Gazette act Miscellaneous
Share issue2 facts ▸
  • Board meeting, 28 juni 2007
  • Share issue, UITGIFTE VAN WARRANTS BINNEN HET TOEGESTAAN KAPITAAL
06-07
State Gazette act Capital & shares · Statutes amendment
Capital increase · Capital3 facts ▸
  • Capital increase, €112.076.435,47
  • Capital, €112.076.435,47
  • Statutes amendment
13-06
State Gazette act Capital & shares · Statutes amendment
Capital increase2 facts ▸
  • Capital increase, €111.873.435,47
  • Statutes amendment
07-05
State Gazette act Capital & shares · Statutes amendment
Capital increase2 facts ▸
  • Capital increase, €111.256.659,15
  • Statutes amendment
30-04
State Gazette act Capital & shares · Statutes amendment
Capital increase · Warrant exercise3 facts ▸
  • Capital increase, €107.920.470,35
  • Statutes amendment
  • Warrant exercise, Vaststelling uitoefening van warrants
08-01
State Gazette act Capital & shares · Statutes amendment
Capital increase · Capital · Power of attorney8 facts ▸
  • Board meeting, 08 december 2006
  • Capital increase, €4.114.000,8
  • Capital, €80.509.601,03
  • Statutes amendment
  • Power of attorney, Johan VAN DEN EYNDE
  • Power of attorney, Peter VERHAEGHE
  • Power of attorney, Stanislas LANCKRIET
  • Power of attorney, Johan VAN DEN EYNDE
2006
02-06
State Gazette act Capital & shares
Share issue2 facts ▸
  • Board meeting, 12 mei 2006
  • Share issue, UITGIFTE VAN WARRANTS BINNEN HET TOEGESTAAN KAPITAAL
22-05
State Gazette act Capital & shares · Statutes amendment
Capital increase · Power of attorney5 facts ▸
  • Capital increase, €70.476.460,54
  • Statutes amendment
  • Power of attorney, Matthieu Derynck
  • Power of attorney, Martin Desimpel
  • Power of attorney, Kamukenji Mpoy
22-05
State Gazette act Resignations & appointments
Share issue · Statutes amendment3 facts ▸
  • Board meeting, 03/02/2006
  • Share issue, Uitgifte van warrants binnen het toegestaan kapitaal
  • Statutes amendment
02-01
State Gazette act Capital & shares · Statutes amendment
Capital increase2 facts ▸
  • Capital increase, €68.979.568,99
  • Statutes amendment
2005
24-06
State Gazette act Capital & shares
Capital increase · Share issue · Capital6 facts ▸
  • Capital increase, €2.028.565
  • Share issue, aandelen op naam, 289795
  • Capital, €49.909.213,34
  • Statutes amendment
  • Bank account, bijzondere rekening te dien einde geopend bij KBC Bank
  • General meeting, 29/03/2005
22-06
State Gazette act Appointments: Raj Parekh, Onno van de Stolpe and 5 others
Resignations: Stephen Bunting, Steven Burrill and 2 others · Capital increase · Capital16 facts ▸
  • Director appointment, Raj Parekh (director)
  • Director appointment, Onno van de Stolpe (director)
  • Director appointment, Laurent Ganem (director)
  • Director appointment, Harrold van Barlingen (director)
  • Director appointment, Barry Ross (independent director)
  • Director appointment, Wilson Totten (independent director)
  • Director appointment, Ferdinand Verdonck (independent director)
  • Director resignation, Stephen Bunting (director)
  • Director resignation, Steven Burrill (director)
  • Director resignation, Ronald Brus (director)
  • Director resignation, Dirk Pollet (director)
  • Capital increase, €19.999.476,5
  • +4 further facts in this act
07-03
State Gazette act Capital & shares · Statutes amendment · Miscellaneous
Correction · Mandate compensation · Warrant grant7 facts ▸
  • General meeting, 07/02/2005
  • Corporate decision, Akkoord met initiëren van een IPO proces en toepassing van Green Shoe-principe (kapitaalverhoging tot 15% bij overinschrijving)
  • Correction, Rechtzetting benoeming Deloitte (geen herbenoeming in 2004, maar voortzetting mandaat van 2003)
  • Mandate compensation, Dirk Pollet
  • Mandate compensation, Onno van de Stolpe
  • Warrant grant, warranten, 60.000
  • Warrant grant, warranten, 125.000
2004
21-06
State Gazette act Reappointments: Ronald Brus, Stephen Bunting and 5 others
Appointment: Deloitte en Touche (commissaris revisor) · Director discharge · Approval13 facts ▸
  • General meeting, 06/04/2004
  • Director reappointment, Ronald Brus (director)
  • Director reappointment, Stephen Bunting (director)
  • Director reappointment, Laurent Ganem (director)
  • Director reappointment, Dirk Pollet (director)
  • Director reappointment, Onno van de Stolpe (director)
  • Director reappointment, G. Steven Burrill (director)
  • Director reappointment, Barry Ross (independent director)
  • Director discharge, Galapagos Genomics NV
  • Auditor appointment, Deloitte en Touche (commissaris revisor)
  • Approval, goedkeuring van de jaarrekening en de daarbij horende verslagen
  • Approval, goedkeuring van het bijzonder Verslag van de Raad van Bestuur met betrekking tot artikel 633 van de Vennootschappenwet
  • +1 further facts in this act
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
202 of 206 acts read
About the unread acts

Of the 206 Belgian State Gazette acts we know for this company, 202 have been read. The other 4 have not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
29 directors, last change in 2026
Paulo Fontoura
Niet uitvoerende onafhankelijke bestuurder · since 09-02-2026
Current
Devang Bhuva
Niet uitvoerende niet onafhankelijke bestuurder · since 01-11-2025
Current
Dr. Neil Johnston
Niet uitvoerende onafhankelijke bestuurder · since 01-11-2025
Current
Fred Blakeslee
General counsel en lid van het directiecomité · since 16-10-2025
Current
Dawn Svoronos
Niet uitvoerende onafhankelijke bestuurder · since 28-07-2025
Current
Jane Griffiths
Niet uitvoerende onafhankelijke bestuurder · since 28-07-2025
Current
23 other directors
Aaron Cox
Chief financial officer · since 07-07-2025
Current
Henry Gosebruch
Chief executive officer · since 12-05-2025
Current
Oleg Nodelman
Niet uitvoerende en niet onafhankelijke bestuurder · since 07-10-2024
Current
Valeria Criossen
General counsel · since 01-01-2024
Current
Thad Hudson
Chief financial officer en chief operating officer · since 01-07-2023
Current
Dan G. Baker
Independent director · since 12-06-2023
Current
Paul Stoffels
Chair of the board · since 12-06-2023
Current
Andreas Hoekema
Cbo · since 26-04-2022
Current
Dan Baker
Onafhankelijk lid van de raad van bestuur · since 26-04-2022
Current
Jérôme Contamine
Chair of the board · since 26-04-2022
Current
Daniel O’Day
Director · since 22-10-2019
Current
Linda Higgins
Director · since 22-10-2019
Current
Bart Filius
President, coo & cfo · since 01-12-2014
Current
Katrine Bosley
Onafhankelijk lid van de raad van bestuur · since 27-02-2013
Current
Howard Rowe
Onafhankelijk lid van de raad van bestuur · since 05-08-2010
Current
Dr. Raj Parekh
Director · since 10-05-2005
Current
Werner Cautreels
Director · since 27-04-2010
Not recently confirmed
Dr. Christine Mummery
Independent director · since 30-09-2015
Not recently confirmed
Henricus van Barlingen
Director · since 31-12-2014
Not recently confirmed
Henricus (gezegd "Harrold") van Barlingen
Director · since 29-04-2014
Not recently confirmed
Harrold van Barlingen
Director · since 10-05-2005
Not recently confirmed
Radan Spaventi
Member of the executive committee · since 24-09-2010
Not recently confirmed
G. Steven Burrill
Director · since 06-04-2004
Not recently confirmed
09-07-2026 Paulo Pacheco da Fontoura: Resigned as Niet uitvoerend onafhankelijk bestuurder
09-02-2026 Paulo Fontoura: Appointed as Niet uitvoerende onafhankelijke bestuurder
31-12-2025 Annelies Missotten: Resigned as Lid van het directiecomité als chief human resources officer
01-11-2025 Devang Bhuva: Appointed as Niet uitvoerende niet onafhankelijke bestuurder
01-11-2025 Dr. Neil Johnston: Appointed as Niet uitvoerende onafhankelijke bestuurder
Full history in the Timeline (263 changes) →See the board, name and seat on a given date →
Not every act has been read: a resignation may be missing here
4 of this company's 206 Belgian State Gazette acts have not been read yet. Appointments and resignations recorded in them are missing above: a director who resigned there may therefore still show here as sitting. The acts are in the Timeline.
Location & real-estate footprint
Registered office, Mechelen · 1 establishment unit since 2018
seat establishment approximate The establishment unit on the map
Ground area
6,622 m²
Building footprint
1,872 m²
Volume, LiDAR
16,687 m³
2 parcels, Flanders · tallest building 24.9 m, ±6 floors. Linked by address, not a title deed.
67 companies at this address See who is registered here
1 establishment unit
Galapagos
Schaliënhoevedreef 20, 2800 MechelenScientific research and development
since 20182.273.734.339
2 parcels
Flanders 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
12402A0204/00R000 Flanders 3,774 m² 1 · 1,004 m² 24.9 m · 6 fl.
12402A0204/00C002 Flanders 2,848 m² 1 · 867 m² -
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Statutory auditor

2 auditors
BDO BEDRIJFSREVISOREN-BDO REVISEURS D'ENTREPRISESCurrent
Commissaris voor de waarborging van de duurzaamheidsverslaggeving · represented by Ellen Lombaerts
04-07-2024 → present
BDO BEDRIJFSREVISOREN-BDO REVISEURS D'ENTREPRISESCurrent
Statutory auditor · represented by Ellen Lombaerts
21-02-2024 → present
Show 2 earlier auditors
Deloitte bedrijfsrevisoren CVBA
Statutory auditor · represented by Nico Houthaeve
succeeded by BDO BEDRIJFSREVISOREN-BDO REVISEURS D'ENTREPRISES in 2024
16-08-2010 → 21-02-2024
Deloitte en Touche
Commissaris revisor
succeeded by Deloitte bedrijfsrevisoren CVBA in 2010
21-06-2004 → 16-08-2010

Articles of association

Other provisions of the articles (25)
  • Board rule: CO-Charter van de Vennootschap, zoals van tijd tot tijd gewijzigd, alle bevoegdheden die nodig zijn voor het uitvoerend beheer en de werking van de Vennootschap
  • Board rule: onderzoeken, bepalen en verkennen van zakelijke opportuniteiten, CEO
  • Board rule: opstellen en uitwerken van strategische richtsnoeren, Raad van Bestuur
  • Board rule (3)
  • Board rule: het opstellen en bijhouden van beleidslijnen met betrekking tot het risicoprofiel van de Vennootschap en systemen om financiële en andere risico's te identifice…
  • Board rule: verantwoordelijk en aansprakelijk zijn voor de volledige, tijdige, betrouwbare en nauwkeurige opstelling van de jaarrekening van de Vennootschap, overeenkomstig…
  • Board rule: verslag uitbrengen aan de Raad van Bestuur over de uitvoering van de strategische beleidslijnen in het algemeen en meer bepaald over de financiële ontwikkeling…
  • Board rule: het uitvoeren van alle andere taken die nodig of nuttig zijn voor de verwezenlijking van het voorwerp van de Vennootschap, met inbegrip van de aangelegenheden d…
  • Board rule: de doeltreffendheid van het CG-Charter te verifiëren en te evalueren en aanbevelingen te doen aan de Raad van Bestuur voor eventuele wijzigingen van het CG-Char…
  • Board rule: ervoor zorgen dat de nodige financiële en menselijke middelen voorhanden zijn opdat de Vennootschap haar doelstellingen kan verwezenlijken, middelen
  • Board rule: het sluiten van collectieve arbeidsovereenkomsten op het niveau van de Vennootschap (met uitzondering van de uitvoering van interprofessionele of sectorale coll…
  • Board rule: het vestigen van, creëren, oprichten en deelnemen in partnerships, joint ventures, vennootschappen, samenwerkingsverbanden, vaste inrichtingen, filialen en elke…
  • Other statement: het overdragen, vervreemden, uitoefenen en anderszins gebruiken van enig (stem-, bestuurs-of ander) recht of belang in dergelijke Rechtspersonen
  • Other statement: met inachtneming van de vertegenwoordigingsbevoegdheid in sectie 4 (b), het aangaan, vernieuwen, wijzigen of beëindigen van overeenkomsten of regelingen met doc…
  • Other statement: het verstrekken of verkrijgen, of het verlenen van een mandaat tot het verstrekken of verkrijgen, van enige hypotheek, pand, retentierecht of andere vorm van be…
  • Other statement: het indienen, opdragen, bijwerken, wijzigen, bekrachtigen, overdragen, intrekken of beëindigen van enige neerlegging, toepassing, registratie of indiening in ve…
  • Other statement: het aangaan van een geschil, arbitrage, schikking of andere vorm van geschillenbeslechting met betrekking tot, waarbij of namens de Vennootschap betrokken is (e…
  • Other statement: het aanvragen, verkrijgen en vernieuwen van licenties, vergunningen, goedkeuringen, machtigingen of andere toelatingen die nodig zijn voor de werking van de act…
  • Other statement: het openen en sluiten van bank- of effectenrekeningen van welke aard ook bij financiële instellingen, alsmede het verrichten van elle stortingen op en afhalinge…
  • Other statement: het indienen, opdragen, bijwerken, wijzigen, bekrachtigen, overdragen, intrekken of beëindigen van een neerlegging, inschrijving, registratie of indiening met b…
  • Other statement
  • Other statement: de uitvoering van de dagelijkse correspondentie namens de Vennootschap
  • Other statement: Het Directiecomité heeft het recht en de bevoegdheid om zijn machten (of een deel ervan) te subdelegeren aan elke andere persoon die door hem wordt aangesteld (…

Structure & network

Heads the group GALAPAGOS 2 companies Group, risk and exposure

Connections & network

5 connected companies
Linked via shared directors
PIAS
via Paul Stoffels · Permanent representative
→
Stoffels IMC
via Paul Stoffels · Permanent representative
→
former→
Show 1 more companies with a shared director
former→

Ownership & control

1 subsidiary
GALAPAGOSBE 0466.460.429
controls
Where this company holds controlsubsidiary per the LEI register1

Acquisitions and mergers

1 transaction
Split off to:Galapagos Cell Therapeutics NV
proposal · State Gazette act of 10-10-2025

Capital and shareholders

Shareholders according to the acts
After the capital increase act of 24-06-2005 ↗
  • KBC Securties NV
  • Kempen & Co Corporate Finance BV

The Belgian State Gazette names shareholders only when an act mentions them; the share register itself is not published.

Capital over the years
  1. 23-03-2023 Capital stated in the act · 356,444,938.61 EUR
  2. 03-10-2022 Capital stated in the act · 356,111,899.01 EUR
  3. 24-06-2022 Capital stated in the act · 355,533,029.01 EUR
  4. 24-03-2022 Capital increase of 2,159,600 EUR · 95,500 new shares
  5. 09-12-2021 Capital stated in the act · 354,582,005.11 EUR
  6. 24-09-2021 Capital stated in the act · 354,459,739.11 EUR
  7. 10-06-2021 Capital stated in the act · 354,418,623.11 EUR
  8. 25-03-2021 Capital stated in the act · 354,359,437.71 EUR
Show 64 older capital entries
  1. 11-12-2020 Capital stated in the act · 353,819,443.97 EUR
  2. 29-09-2020 Capital stated in the act · 353,435,739.72 EUR
  3. 08-06-2020 Capital stated in the act · 352,968,964.92 EUR
  4. 25-03-2020 Capital stated in the act · 350,612,693.52 EUR
  5. 20-12-2019 Capital stated in the act · 349,789,183.32 EUR
  6. 07-10-2019 Capital stated in the act · 335,112,010.21 EUR
  7. 06-09-2019 Capital increase · to 333,479,569.76 EUR · in cash
  8. 03-07-2019 Capital stated in the act · 296,534,760.91 EUR
  9. 16-04-2019 Capital stated in the act · 295,407,803.81 EUR
  10. 05-12-2018 Capital stated in the act · 294,599,712.11 EUR
  11. 24-10-2018 Capital increase · to 294,433,084.11 EUR
  12. 17-10-2018 Capital increase · to 293,700,110.26 EUR
  13. 20-07-2018 Capital increase · to 277,679,082.33 EUR
  14. 12-04-2018 Capital increase · to 277,122,928.92 EUR
  15. 11-01-2018 Capital increase · to 275,509,753.48 EUR
  16. 17-10-2017 Capital increase · to 275,287,943.48 EUR
  17. 20-07-2017 Capital increase · to 275,135,922.48 EUR
  18. 12-05-2017 Capital stated in the act · 274,854,440.18 EUR
  19. 04-05-2017 Capital increase · to 251,523,815.18 EUR
  20. 10-01-2017 Capital increase · to 250,187,166.48 EUR
  21. 07-10-2016 Capital increase · to 249,720,553.98 EUR
  22. 16-06-2016 Capital increase · to 249,394,222.78 EUR
  23. 28-04-2016 Capital increase · to 248,632,657.08 EUR
  24. 09-02-2016 Capital increase of 36,575,392.41 EUR
  25. 13-01-2016 Capital increase · to 211,388,857.22 EUR
  26. 12-11-2015 Capital stated in the act · 211,045,322.22 EUR
  27. 15-07-2015 Capital increase · to 210,405,535.62 EUR
  28. 25-06-2015 Capital increase · to 207,747,029.16 EUR
  29. 06-05-2015 Capital increase · to 166,996,209.57 EUR
  30. 29-01-2015 Capital increase · to 163,904,134.89 EUR
  31. 14-11-2014 Capital increase · to 163,868,834.64 EUR
  32. 18-08-2014 Capital increase · to 163,802,508.04 EUR
  33. 30-05-2014 Capital increase · to 162,820,555.17 EUR
  34. 03-02-2014 Capital increase · to 161,171,635.86 EUR
  35. 08-11-2013 Capital increase · to 161,155,270.61 EUR
  36. 24-07-2013 Capital increase · to 160,962,030.82 EUR
  37. 28-05-2013 Capital stated in the act · 160,474,357.19 EUR
  38. 07-05-2013 Capital increase · to 145,884,501.48 EUR
  39. 25-01-2013 Capital increase · to 144,815,588.27 EUR
  40. 03-10-2012 Capital increase · to 143,887,102.43 EUR
  41. 01-08-2012 Capital increase · to 143,770,414.14 EUR
  42. 14-05-2012 Capital increase · to 143,669,252.55 EUR
  43. 17-01-2012 Capital increase · to 142,928,662.81 EUR
  44. 05-08-2011 Capital increase · to 142,920,142.06 EUR
  45. 27-04-2011 Capital increase · to 142,874,773.80 EUR
  46. 31-12-2010 Capital increase · to 142,590,770.44 EUR
  47. 19-11-2010 Capital increase · to 142,178,761.07 EUR
  48. 04-10-2010 Capital increase · to 129,252,393.80 EUR
  49. 20-07-2010 Capital increase · to 129,233,772.58 EUR
  50. 04-05-2010 Capital increase · to 129,016,506.98 EUR
  51. 05-01-2010 Capital increase · to 127,723,203.20 EUR
  52. 30-11-2009 Capital stated in the act · 126,820,639.20 EUR
  53. 30-09-2009 Capital increase · to 115,276,866.45 EUR
  54. 04-05-2009 Capital increase · to 115,068,666.45 EUR
  55. 06-07-2007 Capital increase · to 112,076,435.47 EUR
  56. 13-06-2007 Capital increase · to 111,873,435.47 EUR
  57. 07-05-2007 Capital increase · to 111,256,659.15 EUR
  58. 30-04-2007 Capital increase · to 107,920,470.35 EUR
  59. 08-01-2007 Capital increase of 4,114,000.80 EUR · 466,440 new shares
  60. 22-05-2006 Capital increase · to 70,476,460.54 EUR · 12,948,781 new shares
  61. 02-01-2006 Capital increase · to 68,979,568.99 EUR
  62. 24-06-2005 Capital increase of 2,028,565 EUR · 289,795 new shares
  63. 22-06-2005 Capital increase of 19,999,476.50 EUR · 2,857,142 new shares
  64. 22-06-2005 Capital increase of 390,010.16 EUR · 84,674 new shares

Public money · subsidies and aid

Flemish government

2022 to 2025 · 10 entries · 4,813,790 EUR awarded · 3,004,785 EUR paid
Year Entries awardedpaid
2025 3 2,386 EUR2,386 EUR
2024 3 3,487,483 EUR1,935,429 EUR
2023 2 30,054 EUR369,054 EUR
2022 2 1,293,867 EUR697,916 EUR
Schemes
5 entries · 4,758,005 EUR · 2,949,000 EUR paid · Fonds voor Innoveren en Ondernemen
5 entries · 55,785 EUR · 55,785 EUR paid · Departement Werk en Sociale Economie

European research

3 projects · 409,800 EUR EU contribution
Programmes
1 entry · 409,800 EUR
2 entries
Projects
Developing high-thoughput bioassays for human cancers in zebrafish
Seventh Framework Programme · participant · 01-04-2008 to 31-03-2011 · 409,800 EUR · ZF-CANCER
New Diagnostics for Infectious Diseases: “ND4ID”
Horizon 2020 · partner · 01-03-2016 to 29-02-2020 · ND4ID
Personalised Treatment For Cystic Fibrosis Patients With Ultra-rare CFTR Mutations (and beyond)
Horizon 2020 · participant · 01-01-2018 to 30-06-2025 · HIT-CF

Recognitions · licences · registrations

Legal Entity Identifier

549300QKJ78IY0IOV655
live in the LEI register

Similar companies · same sector, comparable size

Of 1,178 companies in sector 72109 we hold annual accounts for 715. 5 are within a factor 10 of this equity. See the whole sector

Identification & contact

Identification
Legal formPublic limited company
Founded06-07-1999
Fiscal year end31-12
Legal name NL Lakefront Biotherapeutics
Activities, NACEBEL 2025
72101Research and development on biotechnology
72109Other research and development on natural sciences

Scores and ratios are computed by Checked and are not a credit decision.

General meetings

11 convocations
Extraordinary general meeting
on 25-06-2024 at 14u · published 29-03-2024
Agenda
van de Gewone Algemene Vergadering behandeld is, zal de vergadering kort onderbroken worden, om hierna verder te gaan met de buitengewone algemene vergadering, gehouden voor een notaris (de « Buitengewone Algemene Vergadering »). De Gewone Algemene Vergadering en de Buitengewone Algemene Vergadering worden achtereenvolgens gehouden op dinsdag 30 april 2024, vanaf 14 uur (Belgische tijd) op de zetel van de Vennootschap (Generaal De Witte- laan L11 A3, 2800 Mechelen, België) (samen, de « Algemene Vergade- ringen »). Er is geen aanwezigheidsquorum vereist voor de beraadslaging en stemming over de agendapunten vermeld in de onderstaande agenda van de Gewone Algemene Vergadering. Er is wel een aa ...
Extraordinary general meeting
on 26-04-2022 at 13u · published 25-03-2022
Agenda
van de algemene vergaderingen, dit voorafgaand en schriftelijk doen. De modaliteiten van voormelde wijzen van deelname aan de algemene vergaderingen worden uiteengezet in deze oproeping en in de betreffende formulieren voor de stemming per brief of per volmacht. 1. Buitengewone Algemene Vergadering De buitengewone algemene vergadering van de Vennootschap (hierna de “Buitengewone Algemene Vergadering”) zal worden gehouden in het bijzijn van een notaris, en zal plaatsvinden op dinsdag 26 april 2022, om 13 uur (Belgische tijd) op de zetel van de Vennoot- schap. Overeenkomstig het Wetboek van Vennootschappen en Verenigingen (hierna het “WVV« ) moet minstens een aanwezigheidsquorum van 50 % van d ...
Extraordinary general meeting
on 22-10-2019 at 14u · published 20-09-2019
Agenda
en voorstellen tot besluit De agenda en de voorstellen tot besluit van de bijzondere algemene vergadering van de Vennootschap, die, in voorkomend geval, tijdens de vergadering namens de raad van bestuur van de Vennootschap kunnen worden gewijzigd, zijn als volgt : 1. Benoeming van een bestuurder Voorstel van besluit : de algemene vergadering besluit om Dhr. Daniel O’Day te benoemen als niet-onafhankelijke bestuurder van de Vennootschap voor een termijn die onmiddellijk aanvangt en die een einde neemt onmiddellijk na de jaarlijkse algemene vergadering van de Vennootschap te houden in 2023, op voorstel van de raad van bestuur en in overeenstemming met het advies van het benoemings- en remunera ...
Ordinary general meeting
on 30-04-2019 at 14u · published 29-03-2019
Agenda
en voorstellen tot besluit : Gewoon gedeelte 1. Kennisname en bespreking van het jaarverslag van de raad van bestuur betreffende de statutaire en geconsolideerde jaarrekening van de Vennootschap over het boekjaar geëindigd op 31 december 2018, en van het verslag van de commissaris over de statutaire jaarrekening van de Vennootschap over het boekjaar geëindigd op 31 december 2018. 2. Kennisname en goedkeuring van de statutaire jaarrekening van de Vennootschap over het boekjaar geëindigd op 31 december 2018, en goedkeuring van de door de raad van bestuur voorgestelde bestem- ming van het jaarresultaat. Voorstel van besluit : de algemene vergadering besluit om de statutaire jaarrekening van de ...
Ordinary general meeting
on 24-04-2018 at 14u · published 23-03-2018
Agenda
en voorstellen tot besluit 1. Kennisname en bespreking van het jaarverslag van de raad van bestuur betreffende de statutaire en geconsolideerde jaarrekening van de Vennootschap over het boekjaar geëindigd op 31 december 2017, en van het verslag van de commissaris over de statutaire jaarrekening van de Vennootschap over het boekjaar geëindigd op 31 december 2017. 2. Kennisname en goedkeuring van de statutaire jaarrekening van de Vennootschap over het boekjaar geëindigd op 31 december 2017 en goedkeuring van de door de raad van bestuur voorgestelde bestem- ming van het jaarresultaat. Voorstel van besluit : De algemene vergadering besluit om de statutaire jaarrekening van de Vennootschap over h ...
Show 6 more convocations
Extraordinary general meeting
on 25-04-2017 at 14u · published 24-03-2017
Agenda
en voorstellen tot besluit Gewoon gedeelte 1. Kennisname en bespreking van het jaarverslag van de raad van bestuur betreffende de statutaire en geconsolideerde jaarrekening van de Vennootschap over het boekjaar geëindigd op 31 december 2016, en van het verslag van de commissaris over de statutaire jaarrekening van de Vennootschap over het boekjaar geëindigd op 31 december 2016. 2. Kennisname en goedkeuring van de statutaire jaarrekening van de Vennootschap over het boekjaar geëindigd op 31 december 2016 en goedkeuring van de door de raad van bestuur voorgestelde bestem- ming van het jaarresultaat. Voorstel van besluit : De algemene vergadering besluit om de statu- taire jaarrekening van de V ...
General meeting
on 22-12-2015 at 14u · published 20-11-2015
Agenda
en voorstellen tot besluit 1. Bevestiging van benoeming Onafhankelijke Bestuurder. Voorstel van besluit : de Algemene Vergadering besluit om de benoeming als Bestuurder van de Vennootschap van Dr. Christine Mummery (wonende te Bilthoven, Nederland) door de Raad van Bestuur ter invulling van een vacature, met ingang vanaf 30 september 2015, te bekrachtigen en om haar te benoemen als Bestuurder van de Vennootschap voor een periode van vier jaar die een einde neemt onmiddellijk na de Algemene Vergadering in 2019 die de goedkeuring van de jaarrekening op haar agenda heeft. Op voorstel van de Raad van Bestuur en in overeenstemming met het advies van het Benoemings- en Remuneratiecomité van de Ven ...
Extraordinary general meeting
on 19-05-2014 · at the registered office · published 02-05-2014
Agenda
punten niet werd bereikt tijdens de eerste Vergadering van 29 april 2014. Agenda en voorstellen tot besluit 1. Wijziging van de statuten van de Vennootschap (a) Kennisname en bespreking van het bijzonder verslag van de Raad van Bestuur, opgemaakt overeenkomstig artikel 604 van het Wetboek van vennootschappen, in verband met de hernieuwing van zijn machtiging met betrekking tot, en het verhogen van, het toegestaan kapitaal. (b) Hernieuwing van de machtiging aan de Raad van Bestuur tot verhoging van het maatschappelijk kapitaal binnen het kader van het toegestaan kapitaal. Voorstel van besluit : De Algemene Vergadering besluit tot hernieu- wing van de machtiging aan de Raad van Bestuur om het ...
Ordinary general meeting
on 30-04-2013 at 10u · published 29-03-2013
Agenda
1. Kennisname en bespreking van het jaarverslag van de Raad van Bestuur betreffende de statutaire en geconsolideerde jaarrekening van de Vennootschap over het boekjaar geëindigd op 31 december 2012, en van het verslag van de Commissaris over de statutaire jaarrekening van de Vennootschap over het boekjaar geëindigd op 31 december 2012. 2. Kennisname en goedkeuring van de statutaire jaarrekening van de Vennootschap over het boekjaar geëindigd op 31 december 2012 en goedkeuring van de door de Raad van Bestuur voorgestelde bestem- ming van het jaarresultaat. Voorstel van besluit : De Algemene Aandeelhoudersvergadering besluit om de statutaire jaarrekening van de Vennootschap over het boekjaar g ...
Extraordinary general meeting
on 22-08-2012 at 11u · published 20-07-2012
Agenda
, plaatsvinden op donderdag 13 september 2012 om 11 uur in het kantoor van notaris Matthieu Derynck, Verenigingstraat 30, te 1000 Brussel. Agenda en voorstellen tot besluit Aanbod van warrants aan de Bestuurders van de Vennootschap De besluiten van deze Buitengewone Algemene Aandeelhouders- vergadering met betrekking tot de uitgifte van warrants aan Bestuur- ders van de Vennootschap, kunnen slechts worden uitgevoerd indien de Autoriteit voor Financiële Diensten en Markten (FSMA) aan de Vennootschap heeft meegedeeld geen bezwaar te moeten maken tegen de in dit agendapunt opgenomen uitgifte van warrants. 1. Kennisname en bespreking van de bijzondere verslagen van de Raad van Bestuur opgesteld ...
Extraordinary general meeting
on 23-05-2011 at 11u · published 03-05-2011
Agenda
punten niet werd bereikt tijdens de eerste vergade- ring van 26 april 2011. Agenda van de buitengewone algemene aandeelhoudersvergadering 1. Wijzigingen aan de statuten van de Vennootschap. 1.1. Kennisname en bespreking van het bijzonder verslag van de raad van bestuur, opgemaakt overeenkomstig artikel 604 van het Belgisch Wetboek van Vennootschappen, in verband met de hernieuwing van zijn machtiging met betrekking tot, en de verhoging van, het toegestaan kapitaal. 1.2. Hernieuwing van de machtiging aan de raad van bestuur tot verhoging van het maatschappelijk kapitaal binnen het kader van het toegestaan kapitaal. Voorstel van besluit : De buitengewone algemene aandeelhouders- vergadering be ...